Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF CELL PROLIFERATION |
162 |
1496 |
3.422e-74 |
1.592e-70 |
2 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
168 |
1672 |
2.39e-72 |
5.56e-69 |
3 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
149 |
1395 |
1.367e-66 |
2.121e-63 |
4 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
136 |
1142 |
4.841e-66 |
5.632e-63 |
5 |
REGULATION OF CELL DIFFERENTIATION |
151 |
1492 |
2.257e-64 |
2.101e-61 |
6 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
161 |
1848 |
6.837e-60 |
5.302e-57 |
7 |
REGULATION OF CELL DEATH |
141 |
1472 |
1.576e-56 |
9.542e-54 |
8 |
TISSUE DEVELOPMENT |
143 |
1518 |
1.641e-56 |
9.542e-54 |
9 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
133 |
1381 |
3.205e-53 |
1.657e-50 |
10 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
103 |
788 |
9.495e-53 |
4.017e-50 |
11 |
CIRCULATORY SYSTEM DEVELOPMENT |
103 |
788 |
9.495e-53 |
4.017e-50 |
12 |
RESPONSE TO ENDOGENOUS STIMULUS |
135 |
1450 |
2.357e-52 |
9.138e-50 |
13 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
104 |
823 |
7.439e-52 |
2.663e-49 |
14 |
VASCULATURE DEVELOPMENT |
82 |
469 |
1.317e-51 |
4.37e-49 |
15 |
CELL DEVELOPMENT |
133 |
1426 |
1.409e-51 |
4.37e-49 |
16 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
113 |
1021 |
1.253e-50 |
3.644e-48 |
17 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
99 |
771 |
7.25e-50 |
1.984e-47 |
18 |
POSITIVE REGULATION OF GENE EXPRESSION |
142 |
1733 |
1.506e-48 |
3.892e-46 |
19 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
144 |
1805 |
6.682e-48 |
1.636e-45 |
20 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
146 |
1929 |
7.665e-46 |
1.783e-43 |
21 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
105 |
1008 |
2.662e-44 |
5.898e-42 |
22 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
104 |
1004 |
1.262e-43 |
2.668e-41 |
23 |
BLOOD VESSEL MORPHOGENESIS |
67 |
364 |
1.655e-43 |
3.347e-41 |
24 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
102 |
983 |
8.403e-43 |
1.629e-40 |
25 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
136 |
1784 |
1.248e-42 |
2.323e-40 |
26 |
POSITIVE REGULATION OF CELL COMMUNICATION |
125 |
1532 |
7.052e-42 |
1.262e-39 |
27 |
RESPONSE TO EXTERNAL STIMULUS |
135 |
1821 |
6.45e-41 |
1.112e-38 |
28 |
NEGATIVE REGULATION OF CELL DEATH |
93 |
872 |
8.052e-40 |
1.338e-37 |
29 |
POSITIVE REGULATION OF CELL PROLIFERATION |
90 |
814 |
9.534e-40 |
1.53e-37 |
30 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
125 |
1618 |
2.178e-39 |
3.379e-37 |
31 |
BIOLOGICAL ADHESION |
100 |
1032 |
2.789e-39 |
4.187e-37 |
32 |
RESPONSE TO HORMONE |
93 |
893 |
5.823e-39 |
8.468e-37 |
33 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
88 |
801 |
1.311e-38 |
1.848e-36 |
34 |
RESPONSE TO LIPID |
92 |
888 |
2.445e-38 |
3.345e-36 |
35 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
127 |
1710 |
2.746e-38 |
3.651e-36 |
36 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
79 |
643 |
4.882e-38 |
6.309e-36 |
37 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
87 |
799 |
7.525e-38 |
9.463e-36 |
38 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
94 |
957 |
2.755e-37 |
3.373e-35 |
39 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
92 |
917 |
3.355e-37 |
4.003e-35 |
40 |
REGULATION OF VASCULATURE DEVELOPMENT |
51 |
233 |
4.577e-37 |
5.324e-35 |
41 |
EPITHELIUM DEVELOPMENT |
93 |
945 |
6.131e-37 |
6.634e-35 |
42 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
123 |
1656 |
5.907e-37 |
6.634e-35 |
43 |
ORGAN MORPHOGENESIS |
88 |
841 |
6.112e-37 |
6.634e-35 |
44 |
EMBRYO DEVELOPMENT |
89 |
894 |
1.131e-35 |
1.196e-33 |
45 |
REGULATION OF MAPK CASCADE |
76 |
660 |
1.323e-34 |
1.368e-32 |
46 |
LOCOMOTION |
97 |
1114 |
3.773e-34 |
3.735e-32 |
47 |
NEUROGENESIS |
109 |
1402 |
3.698e-34 |
3.735e-32 |
48 |
ANGIOGENESIS |
53 |
293 |
5.007e-34 |
4.853e-32 |
49 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
107 |
1360 |
6.097e-34 |
5.789e-32 |
50 |
RESPONSE TO GROWTH FACTOR |
64 |
475 |
4.052e-33 |
3.771e-31 |
51 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
111 |
1492 |
4.294e-33 |
3.918e-31 |
52 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
91 |
1036 |
3.134e-32 |
2.752e-30 |
53 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
91 |
1036 |
3.134e-32 |
2.752e-30 |
54 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
101 |
1275 |
3.684e-32 |
3.174e-30 |
55 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
77 |
740 |
4.955e-32 |
4.192e-30 |
56 |
RESPONSE TO ABIOTIC STIMULUS |
90 |
1024 |
7.005e-32 |
5.82e-30 |
57 |
TUBE DEVELOPMENT |
67 |
552 |
7.39e-32 |
6.033e-30 |
58 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
83 |
876 |
1.236e-31 |
9.916e-30 |
59 |
EMBRYONIC MORPHOGENESIS |
66 |
539 |
1.303e-31 |
1.027e-29 |
60 |
POSITIVE REGULATION OF CELL DEATH |
69 |
605 |
4.069e-31 |
3.156e-29 |
61 |
IMMUNE SYSTEM PROCESS |
126 |
1984 |
4.204e-31 |
3.207e-29 |
62 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
96 |
1192 |
4.756e-31 |
3.569e-29 |
63 |
REGULATION OF CELL DEVELOPMENT |
80 |
836 |
9.276e-31 |
6.851e-29 |
64 |
RESPONSE TO NITROGEN COMPOUND |
81 |
859 |
1.049e-30 |
7.625e-29 |
65 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
93 |
1135 |
1.309e-30 |
9.369e-29 |
66 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
49 |
285 |
2.008e-30 |
1.416e-28 |
67 |
CELL MOTILITY |
79 |
835 |
4.99e-30 |
3.414e-28 |
68 |
LOCALIZATION OF CELL |
79 |
835 |
4.99e-30 |
3.414e-28 |
69 |
POSITIVE REGULATION OF LOCOMOTION |
57 |
420 |
1.112e-29 |
7.498e-28 |
70 |
IMMUNE SYSTEM DEVELOPMENT |
66 |
582 |
1.304e-29 |
8.671e-28 |
71 |
EMBRYONIC ORGAN DEVELOPMENT |
56 |
406 |
1.551e-29 |
1.017e-27 |
72 |
MORPHOGENESIS OF AN EPITHELIUM |
55 |
400 |
6.049e-29 |
3.909e-27 |
73 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
59 |
472 |
9.385e-29 |
5.982e-27 |
74 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
104 |
1517 |
6.62e-28 |
4.163e-26 |
75 |
RESPONSE TO ALCOHOL |
51 |
362 |
2.207e-27 |
1.369e-25 |
76 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
89 |
1152 |
2.277e-27 |
1.394e-25 |
77 |
RESPONSE TO PEPTIDE |
53 |
404 |
6.737e-27 |
4.071e-25 |
78 |
TUBE MORPHOGENESIS |
48 |
323 |
7.268e-27 |
4.336e-25 |
79 |
UROGENITAL SYSTEM DEVELOPMENT |
46 |
299 |
1.94e-26 |
1.143e-24 |
80 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
67 |
689 |
4.124e-26 |
2.398e-24 |
81 |
SKELETAL SYSTEM DEVELOPMENT |
55 |
455 |
4.274e-26 |
2.455e-24 |
82 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
63 |
609 |
4.945e-26 |
2.806e-24 |
83 |
TISSUE MORPHOGENESIS |
59 |
533 |
6.248e-26 |
3.503e-24 |
84 |
REGULATION OF GROWTH |
64 |
633 |
6.928e-26 |
3.837e-24 |
85 |
REGULATION OF IMMUNE SYSTEM PROCESS |
96 |
1403 |
1.417e-25 |
7.757e-24 |
86 |
NEGATIVE REGULATION OF GENE EXPRESSION |
98 |
1493 |
9.185e-25 |
4.969e-23 |
87 |
HEART DEVELOPMENT |
54 |
466 |
9.872e-25 |
5.28e-23 |
88 |
REGULATION OF RESPONSE TO STRESS |
97 |
1468 |
1.033e-24 |
5.459e-23 |
89 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
108 |
1791 |
1.968e-24 |
1.029e-22 |
90 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
58 |
552 |
2.471e-24 |
1.273e-22 |
91 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
56 |
513 |
2.491e-24 |
1.273e-22 |
92 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
58 |
554 |
2.971e-24 |
1.503e-22 |
93 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
51 |
422 |
3.116e-24 |
1.559e-22 |
94 |
RESPONSE TO STEROID HORMONE |
55 |
497 |
3.403e-24 |
1.684e-22 |
95 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
50 |
408 |
4.791e-24 |
2.347e-22 |
96 |
RESPONSE TO WOUNDING |
58 |
563 |
6.745e-24 |
3.269e-22 |
97 |
NEGATIVE REGULATION OF LOCOMOTION |
41 |
263 |
6.993e-24 |
3.355e-22 |
98 |
RESPONSE TO OXYGEN LEVELS |
44 |
311 |
8.482e-24 |
4.027e-22 |
99 |
REGULATION OF CELL ADHESION |
61 |
629 |
1.002e-23 |
4.711e-22 |
100 |
CELL ACTIVATION |
58 |
568 |
1.056e-23 |
4.897e-22 |
101 |
CELL PROLIFERATION |
63 |
672 |
1.063e-23 |
4.897e-22 |
102 |
EPITHELIAL CELL DIFFERENTIATION |
54 |
495 |
1.823e-23 |
8.318e-22 |
103 |
RESPONSE TO ACID CHEMICAL |
44 |
319 |
2.426e-23 |
1.096e-21 |
104 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
44 |
321 |
3.139e-23 |
1.404e-21 |
105 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
38 |
229 |
3.334e-23 |
1.478e-21 |
106 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
56 |
541 |
3.437e-23 |
1.495e-21 |
107 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
56 |
541 |
3.437e-23 |
1.495e-21 |
108 |
REGULATION OF KINASE ACTIVITY |
67 |
776 |
3.583e-23 |
1.543e-21 |
109 |
LEUKOCYTE DIFFERENTIATION |
42 |
292 |
4.857e-23 |
2.073e-21 |
110 |
GLAND DEVELOPMENT |
48 |
395 |
5.955e-23 |
2.519e-21 |
111 |
CELLULAR COMPONENT MORPHOGENESIS |
72 |
900 |
6.206e-23 |
2.602e-21 |
112 |
LEUKOCYTE ACTIVATION |
49 |
414 |
6.62e-23 |
2.75e-21 |
113 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
73 |
926 |
7.108e-23 |
2.927e-21 |
114 |
REGULATION OF EPITHELIAL CELL MIGRATION |
33 |
166 |
7.257e-23 |
2.962e-21 |
115 |
REGULATION OF NEURON DIFFERENTIATION |
56 |
554 |
1.097e-22 |
4.439e-21 |
116 |
REGULATION OF ERK1 AND ERK2 CASCADE |
38 |
238 |
1.385e-22 |
5.556e-21 |
117 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
65 |
750 |
1.421e-22 |
5.651e-21 |
118 |
POSITIVE REGULATION OF MAPK CASCADE |
51 |
470 |
4.322e-22 |
1.691e-20 |
119 |
MUSCLE STRUCTURE DEVELOPMENT |
49 |
432 |
4.324e-22 |
1.691e-20 |
120 |
RESPONSE TO CORTICOSTEROID |
33 |
176 |
5.084e-22 |
1.971e-20 |
121 |
STEM CELL DIFFERENTIATION |
34 |
190 |
5.745e-22 |
2.209e-20 |
122 |
NEURON DIFFERENTIATION |
69 |
874 |
1.177e-21 |
4.489e-20 |
123 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
50 |
465 |
1.7e-21 |
6.429e-20 |
124 |
REGULATION OF RESPONSE TO WOUNDING |
47 |
413 |
2.795e-21 |
1.049e-19 |
125 |
LYMPHOCYTE ACTIVATION |
43 |
342 |
3.157e-21 |
1.175e-19 |
126 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
68 |
872 |
4.75e-21 |
1.754e-19 |
127 |
REGULATION OF TRANSFERASE ACTIVITY |
71 |
946 |
4.99e-21 |
1.828e-19 |
128 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
56 |
602 |
5.986e-21 |
2.176e-19 |
129 |
CONNECTIVE TISSUE DEVELOPMENT |
33 |
194 |
1.229e-20 |
4.432e-19 |
130 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
31 |
167 |
1.281e-20 |
4.585e-19 |
131 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
40 |
304 |
1.54e-20 |
5.47e-19 |
132 |
RESPONSE TO DRUG |
47 |
431 |
1.665e-20 |
5.869e-19 |
133 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
40 |
306 |
1.963e-20 |
6.867e-19 |
134 |
PATTERN SPECIFICATION PROCESS |
46 |
418 |
3.013e-20 |
1.046e-18 |
135 |
REPRODUCTION |
83 |
1297 |
3.735e-20 |
1.287e-18 |
136 |
RESPONSE TO INORGANIC SUBSTANCE |
49 |
479 |
3.766e-20 |
1.288e-18 |
137 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
26 |
112 |
4.531e-20 |
1.539e-18 |
138 |
REGENERATION |
30 |
161 |
4.851e-20 |
1.635e-18 |
139 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
50 |
505 |
6.225e-20 |
2.084e-18 |
140 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
26 |
114 |
7.335e-20 |
2.438e-18 |
141 |
GROWTH |
45 |
410 |
8.845e-20 |
2.919e-18 |
142 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
55 |
616 |
9.276e-20 |
3.04e-18 |
143 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
33 |
207 |
9.871e-20 |
3.212e-18 |
144 |
RESPONSE TO MECHANICAL STIMULUS |
33 |
210 |
1.561e-19 |
5.043e-18 |
145 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
46 |
437 |
1.827e-19 |
5.852e-18 |
146 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
74 |
1087 |
1.836e-19 |
5.852e-18 |
147 |
CELLULAR RESPONSE TO LIPID |
47 |
457 |
1.867e-19 |
5.911e-18 |
148 |
INTRACELLULAR SIGNAL TRANSDUCTION |
91 |
1572 |
3.222e-19 |
1.013e-17 |
149 |
REGULATION OF CELL ACTIVATION |
48 |
484 |
3.397e-19 |
1.061e-17 |
150 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
27 |
133 |
3.601e-19 |
1.117e-17 |
151 |
RESPONSE TO BACTERIUM |
50 |
528 |
4.197e-19 |
1.293e-17 |
152 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
47 |
470 |
5.86e-19 |
1.794e-17 |
153 |
POSITIVE REGULATION OF TRANSPORT |
67 |
936 |
9.134e-19 |
2.778e-17 |
154 |
REGULATION OF OSSIFICATION |
30 |
178 |
9.527e-19 |
2.878e-17 |
155 |
SINGLE ORGANISM CELL ADHESION |
46 |
459 |
1.305e-18 |
3.895e-17 |
156 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
64 |
867 |
1.306e-18 |
3.895e-17 |
157 |
RESPONSE TO EXTRACELLULAR STIMULUS |
45 |
441 |
1.571e-18 |
4.656e-17 |
158 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
28 |
154 |
1.738e-18 |
5.117e-17 |
159 |
RESPONSE TO KETONE |
30 |
182 |
1.825e-18 |
5.342e-17 |
160 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
72 |
1079 |
1.848e-18 |
5.373e-17 |
161 |
EMBRYONIC ORGAN MORPHOGENESIS |
36 |
279 |
2.634e-18 |
7.614e-17 |
162 |
REGULATION OF DEFENSE RESPONSE |
59 |
759 |
3.034e-18 |
8.713e-17 |
163 |
OSSIFICATION |
34 |
251 |
5.155e-18 |
1.471e-16 |
164 |
VASCULOGENESIS |
19 |
59 |
5.977e-18 |
1.696e-16 |
165 |
MESENCHYME DEVELOPMENT |
30 |
190 |
6.369e-18 |
1.796e-16 |
166 |
HOMEOSTATIC PROCESS |
80 |
1337 |
1.092e-17 |
3.06e-16 |
167 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
27 |
152 |
1.341e-17 |
3.736e-16 |
168 |
IN UTERO EMBRYONIC DEVELOPMENT |
37 |
311 |
1.353e-17 |
3.746e-16 |
169 |
REGULATION OF HEMOPOIESIS |
37 |
314 |
1.863e-17 |
5.129e-16 |
170 |
RESPONSE TO OXIDATIVE STRESS |
39 |
352 |
2.067e-17 |
5.658e-16 |
171 |
AGING |
34 |
264 |
2.524e-17 |
6.869e-16 |
172 |
REGULATION OF BINDING |
35 |
283 |
3.083e-17 |
8.33e-16 |
173 |
NEGATIVE REGULATION OF NEURON DEATH |
28 |
171 |
3.097e-17 |
8.33e-16 |
174 |
CELL CELL ADHESION |
51 |
608 |
3.168e-17 |
8.472e-16 |
175 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
25 |
131 |
3.659e-17 |
9.728e-16 |
176 |
CARTILAGE DEVELOPMENT |
26 |
147 |
6.044e-17 |
1.598e-15 |
177 |
TAXIS |
44 |
464 |
6.185e-17 |
1.626e-15 |
178 |
REGIONALIZATION |
36 |
311 |
9.176e-17 |
2.399e-15 |
179 |
LYMPHOCYTE DIFFERENTIATION |
30 |
209 |
9.721e-17 |
2.527e-15 |
180 |
REGULATION OF CELL PROJECTION ORGANIZATION |
48 |
558 |
1.083e-16 |
2.8e-15 |
181 |
CELL FATE COMMITMENT |
31 |
227 |
1.254e-16 |
3.223e-15 |
182 |
REGULATION OF CYTOKINE PRODUCTION |
48 |
563 |
1.541e-16 |
3.919e-15 |
183 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
84 |
1518 |
1.538e-16 |
3.919e-15 |
184 |
RESPIRATORY SYSTEM DEVELOPMENT |
29 |
197 |
1.604e-16 |
4.056e-15 |
185 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
45 |
498 |
1.67e-16 |
4.201e-15 |
186 |
REGULATION OF LIPID METABOLIC PROCESS |
34 |
282 |
1.953e-16 |
4.885e-15 |
187 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
22 |
103 |
2.383e-16 |
5.929e-15 |
188 |
RESPONSE TO ESTROGEN |
30 |
218 |
3.185e-16 |
7.882e-15 |
189 |
MUSCLE CELL DIFFERENTIATION |
31 |
237 |
4.329e-16 |
1.066e-14 |
190 |
WOUND HEALING |
43 |
470 |
5.248e-16 |
1.285e-14 |
191 |
SENSORY ORGAN DEVELOPMENT |
44 |
493 |
5.842e-16 |
1.423e-14 |
192 |
DEVELOPMENTAL GROWTH |
36 |
333 |
8.154e-16 |
1.976e-14 |
193 |
ARTERY DEVELOPMENT |
19 |
75 |
9.012e-16 |
2.173e-14 |
194 |
RHYTHMIC PROCESS |
34 |
298 |
1.054e-15 |
2.527e-14 |
195 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
21 |
98 |
1.075e-15 |
2.565e-14 |
196 |
POSITIVE REGULATION OF KINASE ACTIVITY |
43 |
482 |
1.3e-15 |
3.086e-14 |
197 |
REGULATION OF CELL CELL ADHESION |
38 |
380 |
1.634e-15 |
3.86e-14 |
198 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
21 |
100 |
1.661e-15 |
3.885e-14 |
199 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
21 |
100 |
1.661e-15 |
3.885e-14 |
200 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
34 |
303 |
1.743e-15 |
4.055e-14 |
201 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
39 |
408 |
3.07e-15 |
7.106e-14 |
202 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
21 |
103 |
3.131e-15 |
7.177e-14 |
203 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
21 |
103 |
3.131e-15 |
7.177e-14 |
204 |
HEAD DEVELOPMENT |
52 |
709 |
4.038e-15 |
9.21e-14 |
205 |
ARTERY MORPHOGENESIS |
16 |
51 |
4.097e-15 |
9.299e-14 |
206 |
REGULATION OF INFLAMMATORY RESPONSE |
33 |
294 |
4.561e-15 |
1.03e-13 |
207 |
CHEMICAL HOMEOSTASIS |
58 |
874 |
7.554e-15 |
1.698e-13 |
208 |
MESENCHYMAL CELL DIFFERENTIATION |
23 |
134 |
7.68e-15 |
1.718e-13 |
209 |
HEART MORPHOGENESIS |
28 |
212 |
9.279e-15 |
2.066e-13 |
210 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
52 |
724 |
9.419e-15 |
2.087e-13 |
211 |
ENDOCRINE SYSTEM DEVELOPMENT |
22 |
123 |
1.222e-14 |
2.694e-13 |
212 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
29 |
232 |
1.321e-14 |
2.898e-13 |
213 |
REGULATION OF CELLULAR LOCALIZATION |
72 |
1277 |
1.331e-14 |
2.908e-13 |
214 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
36 |
365 |
1.437e-14 |
3.124e-13 |
215 |
REGULATION OF WNT SIGNALING PATHWAY |
33 |
310 |
2.131e-14 |
4.612e-13 |
216 |
RESPONSE TO CYTOKINE |
51 |
714 |
2.169e-14 |
4.673e-13 |
217 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
47 |
616 |
2.204e-14 |
4.726e-13 |
218 |
POSITIVE REGULATION OF CELL ACTIVATION |
33 |
311 |
2.339e-14 |
4.992e-13 |
219 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
39 |
437 |
2.921e-14 |
6.205e-13 |
220 |
RESPONSE TO INSULIN |
27 |
205 |
3.023e-14 |
6.394e-13 |
221 |
MYELOID CELL DIFFERENTIATION |
26 |
189 |
3.204e-14 |
6.745e-13 |
222 |
REGULATION OF CELL MORPHOGENESIS |
44 |
552 |
3.424e-14 |
7.176e-13 |
223 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
23 |
144 |
3.841e-14 |
8.014e-13 |
224 |
REGULATION OF MAP KINASE ACTIVITY |
33 |
319 |
4.854e-14 |
1.008e-12 |
225 |
RESPONSE TO BIOTIC STIMULUS |
57 |
886 |
4.966e-14 |
1.027e-12 |
226 |
RESPONSE TO ESTRADIOL |
23 |
146 |
5.213e-14 |
1.073e-12 |
227 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
27 |
211 |
6.19e-14 |
1.269e-12 |
228 |
CELLULAR RESPONSE TO STRESS |
80 |
1565 |
7.28e-14 |
1.486e-12 |
229 |
NEURON DEVELOPMENT |
49 |
687 |
7.774e-14 |
1.58e-12 |
230 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
27 |
213 |
7.815e-14 |
1.581e-12 |
231 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
15 |
51 |
8.803e-14 |
1.773e-12 |
232 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
28 |
232 |
9.317e-14 |
1.869e-12 |
233 |
REGULATION OF NEURON DEATH |
29 |
252 |
1.15e-13 |
2.296e-12 |
234 |
IMMUNE RESPONSE |
64 |
1100 |
1.202e-13 |
2.39e-12 |
235 |
POSITIVE REGULATION OF OSSIFICATION |
18 |
84 |
1.222e-13 |
2.42e-12 |
236 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
23 |
152 |
1.265e-13 |
2.487e-12 |
237 |
REGULATION OF TRANSPORT |
87 |
1804 |
1.267e-13 |
2.487e-12 |
238 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
54 |
829 |
1.507e-13 |
2.946e-12 |
239 |
CELLULAR RESPONSE TO PEPTIDE |
30 |
274 |
1.611e-13 |
3.123e-12 |
240 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
30 |
274 |
1.611e-13 |
3.123e-12 |
241 |
MUSCLE TISSUE DEVELOPMENT |
30 |
275 |
1.773e-13 |
3.424e-12 |
242 |
POSITIVE REGULATION OF CELL ADHESION |
35 |
376 |
1.896e-13 |
3.646e-12 |
243 |
SYSTEM PROCESS |
86 |
1785 |
1.918e-13 |
3.674e-12 |
244 |
PROTEIN PHOSPHORYLATION |
58 |
944 |
2.056e-13 |
3.922e-12 |
245 |
MUSCLE ORGAN DEVELOPMENT |
30 |
277 |
2.147e-13 |
4.078e-12 |
246 |
FOREBRAIN DEVELOPMENT |
34 |
357 |
2.207e-13 |
4.175e-12 |
247 |
REGULATION OF PROTEIN LOCALIZATION |
58 |
950 |
2.684e-13 |
5.057e-12 |
248 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
21 |
128 |
2.916e-13 |
5.472e-12 |
249 |
GLIOGENESIS |
24 |
175 |
3.401e-13 |
6.355e-12 |
250 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
20 |
115 |
3.465e-13 |
6.449e-12 |
251 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
29 |
264 |
3.806e-13 |
7.055e-12 |
252 |
NEURON PROJECTION DEVELOPMENT |
42 |
545 |
4.213e-13 |
7.78e-12 |
253 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
25 |
194 |
4.572e-13 |
8.409e-12 |
254 |
CELL CHEMOTAXIS |
23 |
162 |
5.061e-13 |
9.234e-12 |
255 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
23 |
162 |
5.061e-13 |
9.234e-12 |
256 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
31 |
307 |
5.578e-13 |
1.014e-11 |
257 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
28 |
250 |
6.06e-13 |
1.097e-11 |
258 |
DIGESTIVE SYSTEM DEVELOPMENT |
22 |
148 |
6.306e-13 |
1.137e-11 |
259 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
42 |
552 |
6.436e-13 |
1.156e-11 |
260 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
25 |
197 |
6.498e-13 |
1.163e-11 |
261 |
CELL SUBSTRATE ADHESION |
23 |
164 |
6.593e-13 |
1.175e-11 |
262 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
17 |
80 |
6.844e-13 |
1.215e-11 |
263 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
21 |
135 |
8.572e-13 |
1.517e-11 |
264 |
RESPONSE TO METAL ION |
32 |
333 |
9.032e-13 |
1.592e-11 |
265 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
24 |
183 |
9.19e-13 |
1.614e-11 |
266 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
26 |
218 |
9.62e-13 |
1.683e-11 |
267 |
SKELETAL SYSTEM MORPHOGENESIS |
25 |
201 |
1.028e-12 |
1.791e-11 |
268 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
15 |
60 |
1.235e-12 |
2.145e-11 |
269 |
CELL CELL SIGNALING |
50 |
767 |
1.276e-12 |
2.207e-11 |
270 |
ORGAN REGENERATION |
17 |
83 |
1.297e-12 |
2.235e-11 |
271 |
PEPTIDYL TYROSINE MODIFICATION |
24 |
186 |
1.316e-12 |
2.259e-11 |
272 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
21 |
138 |
1.333e-12 |
2.28e-11 |
273 |
GASTRULATION |
22 |
155 |
1.646e-12 |
2.806e-11 |
274 |
REGULATION OF ORGAN MORPHOGENESIS |
27 |
242 |
1.738e-12 |
2.951e-11 |
275 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
23 |
172 |
1.828e-12 |
3.093e-11 |
276 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
22 |
156 |
1.88e-12 |
3.169e-11 |
277 |
REGULATION OF IMMUNE RESPONSE |
53 |
858 |
2.05e-12 |
3.431e-11 |
278 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
20 |
126 |
2.048e-12 |
3.431e-11 |
279 |
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE |
14 |
52 |
2.311e-12 |
3.841e-11 |
280 |
CIRCULATORY SYSTEM PROCESS |
33 |
366 |
2.304e-12 |
3.841e-11 |
281 |
RESPONSE TO NUTRIENT |
24 |
191 |
2.356e-12 |
3.888e-11 |
282 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
24 |
191 |
2.356e-12 |
3.888e-11 |
283 |
REGULATION OF HYDROLASE ACTIVITY |
69 |
1327 |
2.392e-12 |
3.92e-11 |
284 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
17 |
86 |
2.391e-12 |
3.92e-11 |
285 |
OVULATION CYCLE |
19 |
113 |
2.546e-12 |
4.157e-11 |
286 |
CELLULAR RESPONSE TO ACID CHEMICAL |
23 |
175 |
2.64e-12 |
4.295e-11 |
287 |
REGULATION OF CELL GROWTH |
34 |
391 |
2.929e-12 |
4.749e-11 |
288 |
DEVELOPMENTAL MATURATION |
24 |
193 |
2.959e-12 |
4.78e-11 |
289 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
21 |
144 |
3.112e-12 |
5.011e-11 |
290 |
REGULATION OF SYSTEM PROCESS |
39 |
507 |
3.224e-12 |
5.174e-11 |
291 |
NEPHRON DEVELOPMENT |
19 |
115 |
3.521e-12 |
5.631e-11 |
292 |
NEGATIVE REGULATION OF MAPK CASCADE |
21 |
145 |
3.57e-12 |
5.689e-11 |
293 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
33 |
372 |
3.598e-12 |
5.714e-11 |
294 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
29 |
289 |
3.74e-12 |
5.919e-11 |
295 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
26 |
233 |
4.508e-12 |
7.111e-11 |
296 |
MAMMARY GLAND DEVELOPMENT |
19 |
117 |
4.837e-12 |
7.604e-11 |
297 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
15 |
67 |
7.021e-12 |
1.1e-10 |
298 |
REGULATION OF SECRETION |
46 |
699 |
7.922e-12 |
1.237e-10 |
299 |
LEUKOCYTE MIGRATION |
27 |
259 |
8.673e-12 |
1.35e-10 |
300 |
GLIAL CELL DIFFERENTIATION |
20 |
136 |
8.799e-12 |
1.365e-10 |
301 |
REGULATION OF PROTEIN KINASE B SIGNALING |
19 |
121 |
8.952e-12 |
1.384e-10 |
302 |
REGULATION OF DNA BINDING |
17 |
93 |
9.055e-12 |
1.395e-10 |
303 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
19 |
122 |
1.04e-11 |
1.597e-10 |
304 |
PLACENTA DEVELOPMENT |
20 |
138 |
1.159e-11 |
1.774e-10 |
305 |
REGULATION OF LEUKOCYTE PROLIFERATION |
24 |
206 |
1.214e-11 |
1.852e-10 |
306 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
27 |
263 |
1.242e-11 |
1.888e-10 |
307 |
CELL PROJECTION ORGANIZATION |
53 |
902 |
1.371e-11 |
2.077e-10 |
308 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
45 |
684 |
1.375e-11 |
2.077e-10 |
309 |
EYE DEVELOPMENT |
30 |
326 |
1.425e-11 |
2.146e-10 |
310 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
23 |
190 |
1.484e-11 |
2.227e-10 |
311 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
21 |
156 |
1.5e-11 |
2.238e-10 |
312 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
21 |
156 |
1.5e-11 |
2.238e-10 |
313 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
12 |
39 |
1.516e-11 |
2.253e-10 |
314 |
CARDIOCYTE DIFFERENTIATION |
17 |
96 |
1.544e-11 |
2.288e-10 |
315 |
KIDNEY EPITHELIUM DEVELOPMENT |
19 |
125 |
1.617e-11 |
2.382e-10 |
316 |
SEX DIFFERENTIATION |
27 |
266 |
1.617e-11 |
2.382e-10 |
317 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
13 |
49 |
1.75e-11 |
2.569e-10 |
318 |
REGULATION OF NEURON APOPTOTIC PROCESS |
23 |
192 |
1.844e-11 |
2.698e-10 |
319 |
REGULATION OF WOUND HEALING |
19 |
126 |
1.868e-11 |
2.707e-10 |
320 |
OSTEOBLAST DIFFERENTIATION |
19 |
126 |
1.868e-11 |
2.707e-10 |
321 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
31 |
351 |
1.861e-11 |
2.707e-10 |
322 |
RESPONSE TO PURINE CONTAINING COMPOUND |
21 |
158 |
1.922e-11 |
2.777e-10 |
323 |
REGULATION OF DEVELOPMENTAL GROWTH |
28 |
289 |
2.06e-11 |
2.968e-10 |
324 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
20 |
143 |
2.262e-11 |
3.249e-10 |
325 |
CELL DEATH |
56 |
1001 |
2.315e-11 |
3.315e-10 |
326 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
17 |
99 |
2.582e-11 |
3.673e-10 |
327 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
17 |
99 |
2.582e-11 |
3.673e-10 |
328 |
REGULATION OF HOMEOSTATIC PROCESS |
35 |
447 |
2.697e-11 |
3.826e-10 |
329 |
NOTCH SIGNALING PATHWAY |
18 |
114 |
2.888e-11 |
4.085e-10 |
330 |
REGULATION OF CELL CYCLE |
54 |
949 |
2.908e-11 |
4.101e-10 |
331 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
17 |
100 |
3.051e-11 |
4.289e-10 |
332 |
CELLULAR RESPONSE TO ALCOHOL |
18 |
115 |
3.359e-11 |
4.707e-10 |
333 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
16 |
87 |
3.385e-11 |
4.729e-10 |
334 |
POSITIVE REGULATION OF HEMOPOIESIS |
21 |
163 |
3.51e-11 |
4.875e-10 |
335 |
LEUKOCYTE CELL CELL ADHESION |
26 |
255 |
3.504e-11 |
4.875e-10 |
336 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
25 |
236 |
3.676e-11 |
5.091e-10 |
337 |
REGULATION OF CARTILAGE DEVELOPMENT |
14 |
63 |
3.957e-11 |
5.464e-10 |
338 |
REGULATION OF BODY FLUID LEVELS |
37 |
506 |
5.184e-11 |
7.131e-10 |
339 |
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION |
13 |
53 |
5.195e-11 |
7.131e-10 |
340 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
47 |
767 |
5.371e-11 |
7.35e-10 |
341 |
ENDOTHELIUM DEVELOPMENT |
16 |
90 |
5.79e-11 |
7.901e-10 |
342 |
RESPONSE TO FLUID SHEAR STRESS |
11 |
34 |
5.846e-11 |
7.954e-10 |
343 |
RESPONSE TO CARBOHYDRATE |
21 |
168 |
6.268e-11 |
8.503e-10 |
344 |
EPITHELIAL CELL DEVELOPMENT |
22 |
186 |
6.554e-11 |
8.866e-10 |
345 |
REGULATION OF FAT CELL DIFFERENTIATION |
17 |
106 |
7.98e-11 |
1.076e-09 |
346 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
18 |
121 |
8.042e-11 |
1.082e-09 |
347 |
AMEBOIDAL TYPE CELL MIGRATION |
20 |
154 |
8.939e-11 |
1.199e-09 |
348 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
21 |
172 |
9.816e-11 |
1.313e-09 |
349 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
24 |
228 |
1.042e-10 |
1.389e-09 |
350 |
BONE DEVELOPMENT |
20 |
156 |
1.133e-10 |
1.506e-09 |
351 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
15 |
81 |
1.264e-10 |
1.676e-09 |
352 |
DEFENSE RESPONSE |
62 |
1231 |
1.358e-10 |
1.795e-09 |
353 |
CELLULAR MACROMOLECULE LOCALIZATION |
62 |
1234 |
1.498e-10 |
1.975e-09 |
354 |
MULTI MULTICELLULAR ORGANISM PROCESS |
23 |
213 |
1.54e-10 |
2.024e-09 |
355 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
29 |
337 |
1.58e-10 |
2.072e-09 |
356 |
REGULATION OF PROTEOLYSIS |
44 |
711 |
1.699e-10 |
2.221e-09 |
357 |
INFLAMMATORY RESPONSE |
34 |
454 |
1.73e-10 |
2.254e-09 |
358 |
SINGLE ORGANISM BEHAVIOR |
31 |
384 |
1.802e-10 |
2.343e-09 |
359 |
RESPONSE TO FATTY ACID |
15 |
83 |
1.817e-10 |
2.349e-09 |
360 |
REGULATION OF ORGANELLE ORGANIZATION |
60 |
1178 |
1.813e-10 |
2.349e-09 |
361 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
23 |
216 |
2.04e-10 |
2.63e-09 |
362 |
MUSCLE CELL DEVELOPMENT |
18 |
128 |
2.088e-10 |
2.683e-09 |
363 |
NEGATIVE REGULATION OF GROWTH |
24 |
236 |
2.135e-10 |
2.736e-09 |
364 |
RESPONSE TO VITAMIN |
16 |
98 |
2.192e-10 |
2.802e-09 |
365 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
20 |
162 |
2.254e-10 |
2.865e-09 |
366 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
20 |
162 |
2.254e-10 |
2.865e-09 |
367 |
REGULATION OF STEM CELL DIFFERENTIATION |
17 |
113 |
2.26e-10 |
2.865e-09 |
368 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
12 |
48 |
2.275e-10 |
2.877e-09 |
369 |
POSITIVE REGULATION OF GROWTH |
24 |
238 |
2.542e-10 |
3.205e-09 |
370 |
STEM CELL PROLIFERATION |
13 |
60 |
2.791e-10 |
3.51e-09 |
371 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
23 |
220 |
2.947e-10 |
3.696e-09 |
372 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
10 |
30 |
3.168e-10 |
3.952e-09 |
373 |
REGULATION OF PROTEIN IMPORT |
21 |
183 |
3.16e-10 |
3.952e-09 |
374 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
30 |
370 |
3.223e-10 |
4.01e-09 |
375 |
CELLULAR RESPONSE TO KETONE |
14 |
73 |
3.232e-10 |
4.01e-09 |
376 |
PHOSPHORYLATION |
61 |
1228 |
3.38e-10 |
4.182e-09 |
377 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
16 |
101 |
3.492e-10 |
4.301e-09 |
378 |
BEHAVIOR |
36 |
516 |
3.503e-10 |
4.301e-09 |
379 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
21 |
184 |
3.499e-10 |
4.301e-09 |
380 |
TISSUE REMODELING |
15 |
87 |
3.641e-10 |
4.459e-09 |
381 |
CELL JUNCTION ORGANIZATION |
21 |
185 |
3.872e-10 |
4.728e-09 |
382 |
POSITIVE REGULATION OF CELL CELL ADHESION |
24 |
243 |
3.899e-10 |
4.749e-09 |
383 |
REGULATION OF CATABOLIC PROCESS |
44 |
731 |
4.081e-10 |
4.958e-09 |
384 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
13 |
62 |
4.32e-10 |
5.235e-09 |
385 |
GLUCOSE HOMEOSTASIS |
20 |
170 |
5.379e-10 |
6.484e-09 |
386 |
CARBOHYDRATE HOMEOSTASIS |
20 |
170 |
5.379e-10 |
6.484e-09 |
387 |
GLIAL CELL DEVELOPMENT |
14 |
76 |
5.672e-10 |
6.802e-09 |
388 |
EXTRACELLULAR MATRIX DISASSEMBLY |
14 |
76 |
5.672e-10 |
6.802e-09 |
389 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
27 |
312 |
6.078e-10 |
7.27e-09 |
390 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
18 |
137 |
6.501e-10 |
7.756e-09 |
391 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
16 |
106 |
7.314e-10 |
8.681e-09 |
392 |
FAT CELL DIFFERENTIATION |
16 |
106 |
7.314e-10 |
8.681e-09 |
393 |
STRIATED MUSCLE CELL DIFFERENTIATION |
20 |
173 |
7.355e-10 |
8.708e-09 |
394 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
13 |
65 |
8.064e-10 |
9.523e-09 |
395 |
RESPONSE TO ORGANOPHOSPHORUS |
18 |
139 |
8.264e-10 |
9.734e-09 |
396 |
T CELL DIFFERENTIATION |
17 |
123 |
8.78e-10 |
1.032e-08 |
397 |
SECRETION |
38 |
588 |
9.738e-10 |
1.141e-08 |
398 |
EAR DEVELOPMENT |
21 |
195 |
1.027e-09 |
1.2e-08 |
399 |
REGULATION OF PROTEIN SECRETION |
30 |
389 |
1.066e-09 |
1.243e-08 |
400 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
35 |
514 |
1.185e-09 |
1.378e-08 |
401 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
21 |
197 |
1.238e-09 |
1.437e-08 |
402 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
29 |
368 |
1.242e-09 |
1.437e-08 |
403 |
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
12 |
55 |
1.254e-09 |
1.448e-08 |
404 |
CANONICAL WNT SIGNALING PATHWAY |
15 |
95 |
1.31e-09 |
1.508e-08 |
405 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
20 |
179 |
1.348e-09 |
1.549e-08 |
406 |
POSITIVE REGULATION OF BINDING |
17 |
127 |
1.455e-09 |
1.664e-08 |
407 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
13 |
68 |
1.455e-09 |
1.664e-08 |
408 |
PROTEIN LOCALIZATION |
77 |
1805 |
1.468e-09 |
1.674e-08 |
409 |
CARDIAC CHAMBER DEVELOPMENT |
18 |
144 |
1.478e-09 |
1.682e-08 |
410 |
MYELOID LEUKOCYTE DIFFERENTIATION |
15 |
96 |
1.523e-09 |
1.728e-08 |
411 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
12 |
56 |
1.566e-09 |
1.769e-08 |
412 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
12 |
56 |
1.566e-09 |
1.769e-08 |
413 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
19 |
163 |
1.709e-09 |
1.925e-08 |
414 |
RESPONSE TO ACTIVITY |
13 |
69 |
1.759e-09 |
1.977e-08 |
415 |
GLAND MORPHOGENESIS |
15 |
97 |
1.767e-09 |
1.981e-08 |
416 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
18 |
146 |
1.852e-09 |
2.072e-08 |
417 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
17 |
129 |
1.86e-09 |
2.075e-08 |
418 |
REGULATION OF T CELL PROLIFERATION |
18 |
147 |
2.07e-09 |
2.305e-08 |
419 |
NEGATIVE REGULATION OF CELL ADHESION |
22 |
223 |
2.168e-09 |
2.408e-08 |
420 |
KIDNEY VASCULATURE DEVELOPMENT |
8 |
19 |
2.226e-09 |
2.46e-08 |
421 |
RENAL SYSTEM VASCULATURE DEVELOPMENT |
8 |
19 |
2.226e-09 |
2.46e-08 |
422 |
NEURON PROJECTION MORPHOGENESIS |
30 |
402 |
2.311e-09 |
2.548e-08 |
423 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
10 |
36 |
2.394e-09 |
2.633e-08 |
424 |
REGULATION OF HORMONE LEVELS |
33 |
478 |
2.556e-09 |
2.804e-08 |
425 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
14 |
85 |
2.64e-09 |
2.89e-08 |
426 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
29 |
381 |
2.751e-09 |
3.005e-08 |
427 |
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
12 |
59 |
2.966e-09 |
3.232e-08 |
428 |
ENDOTHELIAL CELL DIFFERENTIATION |
13 |
72 |
3.047e-09 |
3.312e-08 |
429 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
28 |
360 |
3.23e-09 |
3.503e-08 |
430 |
REGULATION OF LIPID KINASE ACTIVITY |
11 |
48 |
3.542e-09 |
3.833e-08 |
431 |
REGULATION OF SPROUTING ANGIOGENESIS |
9 |
28 |
3.611e-09 |
3.898e-08 |
432 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
15 |
102 |
3.619e-09 |
3.898e-08 |
433 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
12 |
60 |
3.638e-09 |
3.9e-08 |
434 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
12 |
60 |
3.638e-09 |
3.9e-08 |
435 |
SECRETION BY CELL |
33 |
486 |
3.861e-09 |
4.13e-08 |
436 |
REGULATION OF DNA METABOLIC PROCESS |
27 |
340 |
3.975e-09 |
4.242e-08 |
437 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
32 |
462 |
4.153e-09 |
4.422e-08 |
438 |
RESPONSE TO ETHANOL |
17 |
136 |
4.235e-09 |
4.489e-08 |
439 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
17 |
136 |
4.235e-09 |
4.489e-08 |
440 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
25 |
296 |
4.377e-09 |
4.629e-08 |
441 |
REGULATION OF INTRACELLULAR TRANSPORT |
38 |
621 |
4.395e-09 |
4.638e-08 |
442 |
CARDIAC CHAMBER MORPHOGENESIS |
15 |
104 |
4.764e-09 |
5.015e-08 |
443 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
9 |
29 |
5.14e-09 |
5.386e-08 |
444 |
NEURAL CREST CELL DIFFERENTIATION |
13 |
75 |
5.138e-09 |
5.386e-08 |
445 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
16 |
121 |
5.319e-09 |
5.562e-08 |
446 |
ODONTOGENESIS |
15 |
105 |
5.452e-09 |
5.688e-08 |
447 |
RESPONSE TO PROGESTERONE |
11 |
50 |
5.639e-09 |
5.869e-08 |
448 |
ASTROCYTE DIFFERENTIATION |
10 |
39 |
5.659e-09 |
5.878e-08 |
449 |
MESONEPHROS DEVELOPMENT |
14 |
90 |
5.707e-09 |
5.914e-08 |
450 |
MULTICELLULAR ORGANISM REPRODUCTION |
43 |
768 |
5.775e-09 |
5.971e-08 |
451 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
25 |
303 |
7.031e-09 |
7.254e-08 |
452 |
RESPONSE TO RETINOIC ACID |
15 |
107 |
7.109e-09 |
7.318e-08 |
453 |
REGULATION OF BMP SIGNALING PATHWAY |
13 |
77 |
7.178e-09 |
7.373e-08 |
454 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
10 |
40 |
7.405e-09 |
7.59e-08 |
455 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
37 |
606 |
7.529e-09 |
7.699e-08 |
456 |
INOSITOL LIPID MEDIATED SIGNALING |
16 |
124 |
7.628e-09 |
7.784e-08 |
457 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
40 |
691 |
8.088e-09 |
8.235e-08 |
458 |
NEPHRON EPITHELIUM DEVELOPMENT |
14 |
93 |
8.843e-09 |
8.984e-08 |
459 |
REGULATION OF PROTEIN TARGETING |
25 |
307 |
9.157e-09 |
9.283e-08 |
460 |
RESPONSE TO HYDROGEN PEROXIDE |
15 |
109 |
9.213e-09 |
9.319e-08 |
461 |
FORMATION OF PRIMARY GERM LAYER |
15 |
110 |
1.047e-08 |
1.056e-07 |
462 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
11 |
53 |
1.087e-08 |
1.093e-07 |
463 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
11 |
53 |
1.087e-08 |
1.093e-07 |
464 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
47 |
905 |
1.149e-08 |
1.152e-07 |
465 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
14 |
95 |
1.173e-08 |
1.174e-07 |
466 |
REGULATION OF HEART GROWTH |
10 |
42 |
1.238e-08 |
1.236e-07 |
467 |
NEGATIVE REGULATION OF TRANSPORT |
31 |
458 |
1.253e-08 |
1.249e-07 |
468 |
NEGATIVE REGULATION OF CELL CYCLE |
30 |
433 |
1.28e-08 |
1.273e-07 |
469 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
9 |
32 |
1.361e-08 |
1.345e-07 |
470 |
ENDOCARDIAL CUSHION DEVELOPMENT |
9 |
32 |
1.361e-08 |
1.345e-07 |
471 |
PATTERNING OF BLOOD VESSELS |
9 |
32 |
1.361e-08 |
1.345e-07 |
472 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
12 |
67 |
1.365e-08 |
1.346e-07 |
473 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
19 |
185 |
1.418e-08 |
1.395e-07 |
474 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
20 |
207 |
1.677e-08 |
1.646e-07 |
475 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
16 |
131 |
1.699e-08 |
1.664e-07 |
476 |
POSITIVE REGULATION OF ENDOCYTOSIS |
15 |
114 |
1.718e-08 |
1.68e-07 |
477 |
REGULATION OF PROTEIN BINDING |
18 |
168 |
1.76e-08 |
1.717e-07 |
478 |
REGULATION OF CELL DIVISION |
23 |
272 |
1.797e-08 |
1.749e-07 |
479 |
EMBRYONIC PLACENTA DEVELOPMENT |
13 |
83 |
1.843e-08 |
1.79e-07 |
480 |
B CELL ACTIVATION |
16 |
132 |
1.896e-08 |
1.838e-07 |
481 |
REGULATION OF BLOOD PRESSURE |
18 |
169 |
1.932e-08 |
1.869e-07 |
482 |
RESPONSE TO INTERLEUKIN 1 |
15 |
115 |
1.938e-08 |
1.871e-07 |
483 |
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
8 |
24 |
1.975e-08 |
1.902e-07 |
484 |
OUTFLOW TRACT MORPHOGENESIS |
11 |
56 |
2.007e-08 |
1.929e-07 |
485 |
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
10 |
44 |
2.011e-08 |
1.929e-07 |
486 |
REGULATION OF PEPTIDASE ACTIVITY |
28 |
392 |
2.068e-08 |
1.98e-07 |
487 |
RECEPTOR MEDIATED ENDOCYTOSIS |
21 |
231 |
2.152e-08 |
2.056e-07 |
488 |
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
11 |
57 |
2.44e-08 |
2.326e-07 |
489 |
RESPONSE TO PROSTAGLANDIN |
9 |
34 |
2.452e-08 |
2.328e-07 |
490 |
HEART VALVE DEVELOPMENT |
9 |
34 |
2.452e-08 |
2.328e-07 |
491 |
LUNG MORPHOGENESIS |
10 |
45 |
2.537e-08 |
2.399e-07 |
492 |
SPROUTING ANGIOGENESIS |
10 |
45 |
2.537e-08 |
2.399e-07 |
493 |
PEPTIDYL AMINO ACID MODIFICATION |
44 |
841 |
2.825e-08 |
2.666e-07 |
494 |
RESPONSE TO PROSTAGLANDIN E |
8 |
25 |
2.851e-08 |
2.68e-07 |
495 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
8 |
25 |
2.851e-08 |
2.68e-07 |
496 |
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS |
11 |
58 |
2.955e-08 |
2.772e-07 |
497 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
29 |
424 |
2.986e-08 |
2.796e-07 |
498 |
REGULATION OF CYTOSKELETON ORGANIZATION |
32 |
502 |
2.993e-08 |
2.797e-07 |
499 |
WNT SIGNALING PATHWAY |
26 |
351 |
3.223e-08 |
3.005e-07 |
500 |
HOMEOSTASIS OF NUMBER OF CELLS |
18 |
175 |
3.335e-08 |
3.103e-07 |
501 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
12 |
73 |
3.734e-08 |
3.447e-07 |
502 |
PANCREAS DEVELOPMENT |
12 |
73 |
3.734e-08 |
3.447e-07 |
503 |
EMBRYONIC HEART TUBE DEVELOPMENT |
12 |
73 |
3.734e-08 |
3.447e-07 |
504 |
REGULATION OF ORGAN GROWTH |
12 |
73 |
3.734e-08 |
3.447e-07 |
505 |
REGULATION OF COAGULATION |
13 |
88 |
3.803e-08 |
3.504e-07 |
506 |
RESPONSE TO CAMP |
14 |
104 |
3.842e-08 |
3.519e-07 |
507 |
POSITIVE REGULATION OF PROTEIN IMPORT |
14 |
104 |
3.842e-08 |
3.519e-07 |
508 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
14 |
104 |
3.842e-08 |
3.519e-07 |
509 |
REGULATION OF CYTOPLASMIC TRANSPORT |
31 |
481 |
3.864e-08 |
3.532e-07 |
510 |
NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
8 |
26 |
4.043e-08 |
3.688e-07 |
511 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
9 |
36 |
4.24e-08 |
3.846e-07 |
512 |
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT |
9 |
36 |
4.24e-08 |
3.846e-07 |
513 |
NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
9 |
36 |
4.24e-08 |
3.846e-07 |
514 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
15 |
122 |
4.355e-08 |
3.942e-07 |
515 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
28 |
406 |
4.365e-08 |
3.944e-07 |
516 |
REGULATION OF ENDOCYTOSIS |
19 |
199 |
4.641e-08 |
4.185e-07 |
517 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
16 |
141 |
4.881e-08 |
4.393e-07 |
518 |
DIGESTIVE TRACT MORPHOGENESIS |
10 |
48 |
4.916e-08 |
4.408e-07 |
519 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
10 |
48 |
4.916e-08 |
4.408e-07 |
520 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
11 |
61 |
5.126e-08 |
4.587e-07 |
521 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
45 |
891 |
5.473e-08 |
4.888e-07 |
522 |
MYOBLAST DIFFERENTIATION |
9 |
37 |
5.499e-08 |
4.892e-07 |
523 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
9 |
37 |
5.499e-08 |
4.892e-07 |
524 |
PLATELET DEGRANULATION |
14 |
107 |
5.549e-08 |
4.928e-07 |
525 |
RESPONSE TO RADIATION |
28 |
413 |
6.256e-08 |
5.534e-07 |
526 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
14 |
108 |
6.255e-08 |
5.534e-07 |
527 |
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
7 |
19 |
7.057e-08 |
6.231e-07 |
528 |
MESENCHYME MORPHOGENESIS |
9 |
38 |
7.073e-08 |
6.233e-07 |
529 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
10 |
50 |
7.437e-08 |
6.529e-07 |
530 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
10 |
50 |
7.437e-08 |
6.529e-07 |
531 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
13 |
93 |
7.475e-08 |
6.55e-07 |
532 |
REGULATION OF LIPID BIOSYNTHETIC PROCESS |
15 |
128 |
8.334e-08 |
7.289e-07 |
533 |
REGULATION OF PROTEIN ACETYLATION |
11 |
64 |
8.615e-08 |
7.521e-07 |
534 |
ANATOMICAL STRUCTURE MATURATION |
9 |
39 |
9.025e-08 |
7.849e-07 |
535 |
TRABECULA MORPHOGENESIS |
9 |
39 |
9.025e-08 |
7.849e-07 |
536 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
26 |
370 |
9.244e-08 |
8.001e-07 |
537 |
CELL JUNCTION ASSEMBLY |
15 |
129 |
9.251e-08 |
8.001e-07 |
538 |
POSITIVE REGULATION OF SECRETION |
26 |
370 |
9.244e-08 |
8.001e-07 |
539 |
REGULATION OF LIPID TRANSPORT |
13 |
95 |
9.675e-08 |
8.338e-07 |
540 |
MALE SEX DIFFERENTIATION |
16 |
148 |
9.677e-08 |
8.338e-07 |
541 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
18 |
188 |
1.006e-07 |
8.653e-07 |
542 |
CELLULAR RESPONSE TO RETINOIC ACID |
11 |
65 |
1.018e-07 |
8.736e-07 |
543 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
8 |
29 |
1.051e-07 |
8.988e-07 |
544 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
8 |
29 |
1.051e-07 |
8.988e-07 |
545 |
REGULATION OF CYTOKINE SECRETION |
16 |
149 |
1.063e-07 |
9.08e-07 |
546 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
12 |
80 |
1.071e-07 |
9.131e-07 |
547 |
NEGATIVE REGULATION OF BINDING |
15 |
131 |
1.137e-07 |
9.669e-07 |
548 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
9 |
40 |
1.143e-07 |
9.705e-07 |
549 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
19 |
211 |
1.18e-07 |
1e-06 |
550 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
11 |
66 |
1.198e-07 |
1.012e-06 |
551 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
11 |
66 |
1.198e-07 |
1.012e-06 |
552 |
NEGATIVE REGULATION OF CELL GROWTH |
17 |
170 |
1.214e-07 |
1.024e-06 |
553 |
METANEPHROS DEVELOPMENT |
12 |
81 |
1.234e-07 |
1.038e-06 |
554 |
CELLULAR HOMEOSTASIS |
37 |
676 |
1.257e-07 |
1.056e-06 |
555 |
VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION |
6 |
13 |
1.271e-07 |
1.066e-06 |
556 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
33 |
563 |
1.309e-07 |
1.095e-06 |
557 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
19 |
213 |
1.37e-07 |
1.144e-06 |
558 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
8 |
30 |
1.407e-07 |
1.171e-06 |
559 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
8 |
30 |
1.407e-07 |
1.171e-06 |
560 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
9 |
41 |
1.437e-07 |
1.194e-06 |
561 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
27 |
404 |
1.444e-07 |
1.198e-06 |
562 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
16 |
153 |
1.539e-07 |
1.274e-06 |
563 |
FEMALE SEX DIFFERENTIATION |
14 |
116 |
1.555e-07 |
1.286e-06 |
564 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
11 |
68 |
1.647e-07 |
1.359e-06 |
565 |
CELL CYCLE ARREST |
16 |
154 |
1.685e-07 |
1.388e-06 |
566 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
15 |
135 |
1.696e-07 |
1.394e-06 |
567 |
CELLULAR CHEMICAL HOMEOSTASIS |
33 |
570 |
1.74e-07 |
1.428e-06 |
568 |
POSITIVE REGULATION OF DNA BINDING |
9 |
42 |
1.796e-07 |
1.468e-06 |
569 |
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
9 |
42 |
1.796e-07 |
1.468e-06 |
570 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
21 |
262 |
1.867e-07 |
1.524e-06 |
571 |
NEGATIVE REGULATION OF OSSIFICATION |
11 |
69 |
1.923e-07 |
1.567e-06 |
572 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
33 |
573 |
1.963e-07 |
1.596e-06 |
573 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
19 |
218 |
1.972e-07 |
1.601e-06 |
574 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
16 |
156 |
2.015e-07 |
1.631e-06 |
575 |
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
16 |
156 |
2.015e-07 |
1.631e-06 |
576 |
RESPONSE TO TOXIC SUBSTANCE |
20 |
241 |
2.092e-07 |
1.69e-06 |
577 |
CELL MATRIX ADHESION |
14 |
119 |
2.146e-07 |
1.73e-06 |
578 |
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT |
6 |
14 |
2.186e-07 |
1.759e-06 |
579 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
7 |
22 |
2.261e-07 |
1.817e-06 |
580 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
10 |
56 |
2.303e-07 |
1.848e-06 |
581 |
POSITIVE REGULATION OF PROTEOLYSIS |
25 |
363 |
2.4e-07 |
1.922e-06 |
582 |
POSITIVE REGULATION OF BMP SIGNALING PATHWAY |
8 |
32 |
2.437e-07 |
1.945e-06 |
583 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
8 |
32 |
2.437e-07 |
1.945e-06 |
584 |
REGULATION OF JNK CASCADE |
16 |
159 |
2.621e-07 |
2.088e-06 |
585 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
15 |
140 |
2.74e-07 |
2.18e-06 |
586 |
REGULATION OF CHEMOTAXIS |
17 |
180 |
2.777e-07 |
2.205e-06 |
587 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
13 |
104 |
2.858e-07 |
2.265e-06 |
588 |
REGULATED EXOCYTOSIS |
19 |
224 |
3.009e-07 |
2.381e-06 |
589 |
VESICLE MEDIATED TRANSPORT |
54 |
1239 |
3.025e-07 |
2.39e-06 |
590 |
MYELOID CELL HOMEOSTASIS |
12 |
88 |
3.138e-07 |
2.471e-06 |
591 |
ESTABLISHMENT OF CELL POLARITY |
12 |
88 |
3.138e-07 |
2.471e-06 |
592 |
NEURON PROJECTION REGENERATION |
8 |
33 |
3.157e-07 |
2.478e-06 |
593 |
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS |
8 |
33 |
3.157e-07 |
2.478e-06 |
594 |
TRABECULA FORMATION |
7 |
23 |
3.192e-07 |
2.5e-06 |
595 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
75 |
1977 |
3.282e-07 |
2.566e-06 |
596 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
16 |
162 |
3.387e-07 |
2.644e-06 |
597 |
POSITIVE REGULATION OF STAT CASCADE |
11 |
73 |
3.479e-07 |
2.707e-06 |
598 |
POSITIVE REGULATION OF JAK STAT CASCADE |
11 |
73 |
3.479e-07 |
2.707e-06 |
599 |
EPITHELIAL CELL PROLIFERATION |
12 |
89 |
3.559e-07 |
2.765e-06 |
600 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
11 |
74 |
4.01e-07 |
3.11e-06 |
601 |
COGNITION |
20 |
251 |
4.022e-07 |
3.114e-06 |
602 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
8 |
34 |
4.054e-07 |
3.133e-06 |
603 |
ENDOCYTOSIS |
30 |
509 |
4.414e-07 |
3.406e-06 |
604 |
CHONDROCYTE DIFFERENTIATION |
10 |
60 |
4.524e-07 |
3.485e-06 |
605 |
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
11 |
75 |
4.611e-07 |
3.547e-06 |
606 |
MODULATION OF SYNAPTIC TRANSMISSION |
22 |
301 |
4.696e-07 |
3.605e-06 |
607 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
21 |
279 |
5.303e-07 |
4.065e-06 |
608 |
HEPATICOBILIARY SYSTEM DEVELOPMENT |
14 |
128 |
5.314e-07 |
4.067e-06 |
609 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
13 |
110 |
5.526e-07 |
4.222e-06 |
610 |
MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION |
6 |
16 |
5.623e-07 |
4.282e-06 |
611 |
MORPHOGENESIS OF AN ENDOTHELIUM |
6 |
16 |
5.623e-07 |
4.282e-06 |
612 |
REGULATION OF REPRODUCTIVE PROCESS |
14 |
129 |
5.849e-07 |
4.447e-06 |
613 |
APPENDAGE DEVELOPMENT |
16 |
169 |
6.022e-07 |
4.564e-06 |
614 |
LIMB DEVELOPMENT |
16 |
169 |
6.022e-07 |
4.564e-06 |
615 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
11 |
77 |
6.057e-07 |
4.576e-06 |
616 |
DIENCEPHALON DEVELOPMENT |
11 |
77 |
6.057e-07 |
4.576e-06 |
617 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
13 |
111 |
6.141e-07 |
4.631e-06 |
618 |
EMBRYONIC HEART TUBE MORPHOGENESIS |
10 |
62 |
6.215e-07 |
4.679e-06 |
619 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
20 |
258 |
6.226e-07 |
4.68e-06 |
620 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
21 |
282 |
6.319e-07 |
4.734e-06 |
621 |
MUSCLE SYSTEM PROCESS |
21 |
282 |
6.319e-07 |
4.734e-06 |
622 |
REGULATION OF INNATE IMMUNE RESPONSE |
24 |
357 |
6.472e-07 |
4.842e-06 |
623 |
RESPONSE TO BMP |
12 |
94 |
6.513e-07 |
4.849e-06 |
624 |
CELLULAR RESPONSE TO BMP STIMULUS |
12 |
94 |
6.513e-07 |
4.849e-06 |
625 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
8 |
36 |
6.511e-07 |
4.849e-06 |
626 |
RESPONSE TO AMINO ACID |
13 |
112 |
6.816e-07 |
5.067e-06 |
627 |
RENAL TUBULE DEVELOPMENT |
11 |
78 |
6.92e-07 |
5.136e-06 |
628 |
GLOMERULUS DEVELOPMENT |
9 |
49 |
7.263e-07 |
5.381e-06 |
629 |
POSITIVE REGULATION OF T CELL PROLIFERATION |
12 |
95 |
7.315e-07 |
5.403e-06 |
630 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
12 |
95 |
7.315e-07 |
5.403e-06 |
631 |
POSITIVE REGULATION OF CELL DIVISION |
14 |
132 |
7.753e-07 |
5.717e-06 |
632 |
CORONARY VASCULATURE DEVELOPMENT |
8 |
37 |
8.156e-07 |
5.995e-06 |
633 |
HINDLIMB MORPHOGENESIS |
8 |
37 |
8.156e-07 |
5.995e-06 |
634 |
REGULATION OF EMBRYONIC DEVELOPMENT |
13 |
114 |
8.369e-07 |
6.142e-06 |
635 |
REGULATION OF MUSCLE SYSTEM PROCESS |
17 |
195 |
8.635e-07 |
6.327e-06 |
636 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
24 |
364 |
9.152e-07 |
6.696e-06 |
637 |
REGULATION OF GTPASE ACTIVITY |
35 |
673 |
9.186e-07 |
6.71e-06 |
638 |
POSITIVE REGULATION OF ORGAN GROWTH |
8 |
38 |
1.014e-06 |
7.374e-06 |
639 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
8 |
38 |
1.014e-06 |
7.374e-06 |
640 |
REGULATION OF GLUCONEOGENESIS |
8 |
38 |
1.014e-06 |
7.374e-06 |
641 |
CELL GROWTH |
14 |
135 |
1.02e-06 |
7.401e-06 |
642 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
12 |
98 |
1.027e-06 |
7.444e-06 |
643 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
25 |
393 |
1.045e-06 |
7.566e-06 |
644 |
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION |
7 |
27 |
1.075e-06 |
7.756e-06 |
645 |
POSITIVE REGULATION OF HEART GROWTH |
7 |
27 |
1.075e-06 |
7.756e-06 |
646 |
REGULATION OF PROTEIN STABILITY |
18 |
221 |
1.115e-06 |
8.033e-06 |
647 |
SPECIFICATION OF SYMMETRY |
13 |
117 |
1.129e-06 |
8.121e-06 |
648 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
25 |
395 |
1.147e-06 |
8.233e-06 |
649 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
23 |
343 |
1.159e-06 |
8.308e-06 |
650 |
ACTIN FILAMENT BASED PROCESS |
27 |
450 |
1.198e-06 |
8.573e-06 |
651 |
NEGATIVE REGULATION OF SECRETION |
17 |
200 |
1.229e-06 |
8.784e-06 |
652 |
CELLULAR RESPONSE TO NUTRIENT |
8 |
39 |
1.253e-06 |
8.926e-06 |
653 |
GLANDULAR EPITHELIAL CELL DIFFERENTIATION |
8 |
39 |
1.253e-06 |
8.926e-06 |
654 |
NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION |
6 |
18 |
1.258e-06 |
8.948e-06 |
655 |
REGULATION OF ION HOMEOSTASIS |
17 |
201 |
1.317e-06 |
9.356e-06 |
656 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
14 |
138 |
1.331e-06 |
9.423e-06 |
657 |
MAINTENANCE OF LOCATION |
14 |
138 |
1.331e-06 |
9.423e-06 |
658 |
TISSUE MIGRATION |
11 |
84 |
1.476e-06 |
1.044e-05 |
659 |
CYTOKINE PRODUCTION |
13 |
120 |
1.509e-06 |
1.066e-05 |
660 |
MAMMARY GLAND MORPHOGENESIS |
8 |
40 |
1.537e-06 |
1.08e-05 |
661 |
FORELIMB MORPHOGENESIS |
8 |
40 |
1.537e-06 |
1.08e-05 |
662 |
ENDOCRINE PANCREAS DEVELOPMENT |
8 |
40 |
1.537e-06 |
1.08e-05 |
663 |
NEURON PROJECTION GUIDANCE |
17 |
205 |
1.729e-06 |
1.213e-05 |
664 |
CELL PART MORPHOGENESIS |
33 |
633 |
1.804e-06 |
1.256e-05 |
665 |
REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS |
6 |
19 |
1.806e-06 |
1.256e-05 |
666 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
6 |
19 |
1.806e-06 |
1.256e-05 |
667 |
ATRIOVENTRICULAR VALVE DEVELOPMENT |
6 |
19 |
1.806e-06 |
1.256e-05 |
668 |
ASTROCYTE DEVELOPMENT |
6 |
19 |
1.806e-06 |
1.256e-05 |
669 |
ESTROUS CYCLE |
6 |
19 |
1.806e-06 |
1.256e-05 |
670 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
7 |
29 |
1.822e-06 |
1.262e-05 |
671 |
REGULATION OF HEART MORPHOGENESIS |
7 |
29 |
1.822e-06 |
1.262e-05 |
672 |
MUSCLE ADAPTATION |
7 |
29 |
1.822e-06 |
1.262e-05 |
673 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
8 |
41 |
1.875e-06 |
1.296e-05 |
674 |
ION HOMEOSTASIS |
31 |
576 |
1.945e-06 |
1.343e-05 |
675 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
9 |
55 |
2.01e-06 |
1.384e-05 |
676 |
REGULATION OF KIDNEY DEVELOPMENT |
9 |
55 |
2.01e-06 |
1.384e-05 |
677 |
HORMONE METABOLIC PROCESS |
15 |
164 |
2.091e-06 |
1.437e-05 |
678 |
REGULATION OF JAK STAT CASCADE |
14 |
144 |
2.218e-06 |
1.52e-05 |
679 |
REGULATION OF STAT CASCADE |
14 |
144 |
2.218e-06 |
1.52e-05 |
680 |
ENDODERM DEVELOPMENT |
10 |
71 |
2.255e-06 |
1.543e-05 |
681 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
8 |
42 |
2.274e-06 |
1.554e-05 |
682 |
BROWN FAT CELL DIFFERENTIATION |
7 |
30 |
2.334e-06 |
1.592e-05 |
683 |
CELLULAR RESPONSE TO INTERLEUKIN 1 |
11 |
88 |
2.358e-06 |
1.602e-05 |
684 |
OVULATION CYCLE PROCESS |
11 |
88 |
2.358e-06 |
1.602e-05 |
685 |
REGULATION OF STEM CELL PROLIFERATION |
11 |
88 |
2.358e-06 |
1.602e-05 |
686 |
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION |
6 |
20 |
2.534e-06 |
1.719e-05 |
687 |
POSITIVE REGULATION OF PROTEIN SECRETION |
17 |
211 |
2.567e-06 |
1.739e-05 |
688 |
B CELL DIFFERENTIATION |
11 |
89 |
2.641e-06 |
1.786e-05 |
689 |
ENDOTHELIAL CELL MIGRATION |
9 |
57 |
2.741e-06 |
1.847e-05 |
690 |
MORPHOGENESIS OF AN EPITHELIAL SHEET |
8 |
43 |
2.743e-06 |
1.847e-05 |
691 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
8 |
43 |
2.743e-06 |
1.847e-05 |
692 |
RESPONSE TO PHENYLPROPANOID |
5 |
12 |
2.83e-06 |
1.897e-05 |
693 |
REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
5 |
12 |
2.83e-06 |
1.897e-05 |
694 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
5 |
12 |
2.83e-06 |
1.897e-05 |
695 |
REGULATION OF OXIDOREDUCTASE ACTIVITY |
11 |
90 |
2.952e-06 |
1.977e-05 |
696 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
23 |
363 |
3.027e-06 |
2.023e-05 |
697 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
16 |
191 |
3.054e-06 |
2.039e-05 |
698 |
INNATE IMMUNE RESPONSE |
32 |
619 |
3.097e-06 |
2.065e-05 |
699 |
NEGATIVE REGULATION OF HEMOPOIESIS |
13 |
128 |
3.134e-06 |
2.086e-05 |
700 |
NEURAL TUBE DEVELOPMENT |
14 |
149 |
3.326e-06 |
2.207e-05 |
701 |
REGULATION OF LEUKOCYTE MIGRATION |
14 |
149 |
3.326e-06 |
2.207e-05 |
702 |
SENSORY ORGAN MORPHOGENESIS |
18 |
239 |
3.413e-06 |
2.26e-05 |
703 |
REGULATION OF ION TRANSPORT |
31 |
592 |
3.415e-06 |
2.26e-05 |
704 |
CELLULAR RESPONSE TO OSMOTIC STRESS |
6 |
21 |
3.485e-06 |
2.303e-05 |
705 |
PROXIMAL DISTAL PATTERN FORMATION |
7 |
32 |
3.721e-06 |
2.449e-05 |
706 |
NEGATIVE REGULATION OF LEUKOCYTE MIGRATION |
7 |
32 |
3.721e-06 |
2.449e-05 |
707 |
BLOOD VESSEL REMODELING |
7 |
32 |
3.721e-06 |
2.449e-05 |
708 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
10 |
75 |
3.756e-06 |
2.468e-05 |
709 |
CELL MATURATION |
13 |
131 |
4.061e-06 |
2.66e-05 |
710 |
REGULATION OF CELLULAR KETONE METABOLIC PROCESS |
15 |
173 |
4.064e-06 |
2.66e-05 |
711 |
REGULATION OF CELL SUBSTRATE ADHESION |
15 |
173 |
4.064e-06 |
2.66e-05 |
712 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
14 |
152 |
4.206e-06 |
2.748e-05 |
713 |
REGULATION OF MONOOXYGENASE ACTIVITY |
9 |
60 |
4.26e-06 |
2.78e-05 |
714 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
13 |
132 |
4.42e-06 |
2.88e-05 |
715 |
CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS |
5 |
13 |
4.519e-06 |
2.929e-05 |
716 |
RESPONSE TO HEPATOCYTE GROWTH FACTOR |
5 |
13 |
4.519e-06 |
2.929e-05 |
717 |
RESPONSE TO PARATHYROID HORMONE |
5 |
13 |
4.519e-06 |
2.929e-05 |
718 |
MESENCHYMAL CELL PROLIFERATION |
5 |
13 |
4.519e-06 |
2.929e-05 |
719 |
RESPONSE TO DEXAMETHASONE |
7 |
33 |
4.637e-06 |
3.001e-05 |
720 |
NEGATIVE REGULATION OF DNA BINDING |
8 |
46 |
4.671e-06 |
3.014e-05 |
721 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
8 |
46 |
4.671e-06 |
3.014e-05 |
722 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
15 |
175 |
4.682e-06 |
3.016e-05 |
723 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
33 |
662 |
4.692e-06 |
3.016e-05 |
724 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
33 |
662 |
4.692e-06 |
3.016e-05 |
725 |
PROTEIN LOCALIZATION TO CELL SURFACE |
6 |
22 |
4.706e-06 |
3.016e-05 |
726 |
AORTA MORPHOGENESIS |
6 |
22 |
4.706e-06 |
3.016e-05 |
727 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
9 |
61 |
4.905e-06 |
3.135e-05 |
728 |
POSITIVE REGULATION OF PEPTIDASE ACTIVITY |
14 |
154 |
4.902e-06 |
3.135e-05 |
729 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
19 |
272 |
5.509e-06 |
3.516e-05 |
730 |
REGULATION OF TISSUE REMODELING |
9 |
62 |
5.632e-06 |
3.59e-05 |
731 |
RESPONSE TO CALCIUM ION |
12 |
115 |
5.653e-06 |
3.598e-05 |
732 |
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS |
14 |
156 |
5.699e-06 |
3.622e-05 |
733 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
7 |
34 |
5.735e-06 |
3.635e-05 |
734 |
PROTEIN KINASE B SIGNALING |
7 |
34 |
5.735e-06 |
3.635e-05 |
735 |
REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
11 |
97 |
6.188e-06 |
3.917e-05 |
736 |
STRIATED MUSCLE ADAPTATION |
6 |
23 |
6.255e-06 |
3.954e-05 |
737 |
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
9 |
63 |
6.45e-06 |
4.072e-05 |
738 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
8 |
48 |
6.51e-06 |
4.083e-05 |
739 |
REGULATION OF MYOBLAST DIFFERENTIATION |
8 |
48 |
6.51e-06 |
4.083e-05 |
740 |
REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS |
8 |
48 |
6.51e-06 |
4.083e-05 |
741 |
POSITIVE REGULATION OF WOUND HEALING |
8 |
48 |
6.51e-06 |
4.083e-05 |
742 |
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
8 |
48 |
6.51e-06 |
4.083e-05 |
743 |
NEGATIVE REGULATION OF CELL ACTIVATION |
14 |
158 |
6.608e-06 |
4.138e-05 |
744 |
RESPONSE TO ALKALOID |
13 |
137 |
6.67e-06 |
4.166e-05 |
745 |
ACTIVATION OF MAPK ACTIVITY |
13 |
137 |
6.67e-06 |
4.166e-05 |
746 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
16 |
203 |
6.692e-06 |
4.174e-05 |
747 |
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
10 |
80 |
6.795e-06 |
4.232e-05 |
748 |
POSITIVE REGULATION OF METANEPHROS DEVELOPMENT |
5 |
14 |
6.908e-06 |
4.263e-05 |
749 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
5 |
14 |
6.908e-06 |
4.263e-05 |
750 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
5 |
14 |
6.908e-06 |
4.263e-05 |
751 |
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS |
5 |
14 |
6.908e-06 |
4.263e-05 |
752 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
5 |
14 |
6.908e-06 |
4.263e-05 |
753 |
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY |
5 |
14 |
6.908e-06 |
4.263e-05 |
754 |
RESPONSE TO LAMINAR FLUID SHEAR STRESS |
5 |
14 |
6.908e-06 |
4.263e-05 |
755 |
TELENCEPHALON DEVELOPMENT |
17 |
228 |
7.278e-06 |
4.485e-05 |
756 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
12 |
118 |
7.39e-06 |
4.548e-05 |
757 |
MYELOID LEUKOCYTE MIGRATION |
11 |
99 |
7.552e-06 |
4.642e-05 |
758 |
REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY |
8 |
49 |
7.639e-06 |
4.659e-05 |
759 |
REGULATION OF FIBROBLAST PROLIFERATION |
10 |
81 |
7.608e-06 |
4.659e-05 |
760 |
CELLULAR RESPONSE TO CALCIUM ION |
8 |
49 |
7.639e-06 |
4.659e-05 |
761 |
REGULATION OF STEROID BIOSYNTHETIC PROCESS |
8 |
49 |
7.639e-06 |
4.659e-05 |
762 |
CARDIAC SEPTUM MORPHOGENESIS |
8 |
49 |
7.639e-06 |
4.659e-05 |
763 |
CARDIAC CELL DEVELOPMENT |
8 |
49 |
7.639e-06 |
4.659e-05 |
764 |
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
6 |
24 |
8.192e-06 |
4.963e-05 |
765 |
POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
6 |
24 |
8.192e-06 |
4.963e-05 |
766 |
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
6 |
24 |
8.192e-06 |
4.963e-05 |
767 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
6 |
24 |
8.192e-06 |
4.963e-05 |
768 |
ERYTHROCYTE DEVELOPMENT |
6 |
24 |
8.192e-06 |
4.963e-05 |
769 |
REGULATION OF CHEMOKINE PRODUCTION |
9 |
65 |
8.395e-06 |
5.079e-05 |
770 |
RECEPTOR METABOLIC PROCESS |
10 |
82 |
8.504e-06 |
5.132e-05 |
771 |
KIDNEY MORPHOGENESIS |
10 |
82 |
8.504e-06 |
5.132e-05 |
772 |
POSITIVE CHEMOTAXIS |
7 |
36 |
8.581e-06 |
5.172e-05 |
773 |
POSITIVE REGULATION OF CHEMOTAXIS |
12 |
120 |
8.793e-06 |
5.293e-05 |
774 |
REGULATION OF PEPTIDE TRANSPORT |
18 |
256 |
8.871e-06 |
5.333e-05 |
775 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
14 |
163 |
9.47e-06 |
5.685e-05 |
776 |
REGULATION OF B CELL ACTIVATION |
12 |
121 |
9.579e-06 |
5.743e-05 |
777 |
RESPONSE TO TUMOR NECROSIS FACTOR |
17 |
233 |
9.692e-06 |
5.804e-05 |
778 |
POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION |
5 |
15 |
1.018e-05 |
6.082e-05 |
779 |
VENOUS BLOOD VESSEL DEVELOPMENT |
5 |
15 |
1.018e-05 |
6.082e-05 |
780 |
EXOCYTOSIS |
20 |
310 |
1.025e-05 |
6.113e-05 |
781 |
LIPID MODIFICATION |
16 |
210 |
1.028e-05 |
6.124e-05 |
782 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
8 |
51 |
1.04e-05 |
6.178e-05 |
783 |
NEURAL CREST CELL MIGRATION |
8 |
51 |
1.04e-05 |
6.178e-05 |
784 |
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
10 |
84 |
1.057e-05 |
6.275e-05 |
785 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
9 |
67 |
1.082e-05 |
6.413e-05 |
786 |
REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
13 |
144 |
1.15e-05 |
6.806e-05 |
787 |
CARDIAC SEPTUM DEVELOPMENT |
10 |
85 |
1.176e-05 |
6.953e-05 |
788 |
REGULATION OF HORMONE SECRETION |
18 |
262 |
1.217e-05 |
7.177e-05 |
789 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
11 |
104 |
1.216e-05 |
7.177e-05 |
790 |
BONE MINERALIZATION |
7 |
38 |
1.251e-05 |
7.35e-05 |
791 |
REGULATION OF STEROL TRANSPORT |
7 |
38 |
1.251e-05 |
7.35e-05 |
792 |
REGULATION OF CHOLESTEROL TRANSPORT |
7 |
38 |
1.251e-05 |
7.35e-05 |
793 |
POSITIVE REGULATION OF B CELL ACTIVATION |
10 |
86 |
1.306e-05 |
7.664e-05 |
794 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
23 |
397 |
1.311e-05 |
7.681e-05 |
795 |
HEART TRABECULA MORPHOGENESIS |
6 |
26 |
1.352e-05 |
7.904e-05 |
796 |
REGULATION OF HORMONE METABOLIC PROCESS |
6 |
26 |
1.352e-05 |
7.904e-05 |
797 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
8 |
53 |
1.395e-05 |
8.134e-05 |
798 |
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
8 |
53 |
1.395e-05 |
8.134e-05 |
799 |
EXTRACELLULAR MATRIX ASSEMBLY |
5 |
16 |
1.456e-05 |
8.435e-05 |
800 |
REGULATION OF FATTY ACID METABOLIC PROCESS |
10 |
87 |
1.449e-05 |
8.435e-05 |
801 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
5 |
16 |
1.456e-05 |
8.435e-05 |
802 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
5 |
16 |
1.456e-05 |
8.435e-05 |
803 |
ATRIOVENTRICULAR VALVE MORPHOGENESIS |
5 |
16 |
1.456e-05 |
8.435e-05 |
804 |
SPINAL CORD DEVELOPMENT |
11 |
106 |
1.46e-05 |
8.44e-05 |
805 |
CARDIAC VENTRICLE DEVELOPMENT |
11 |
106 |
1.46e-05 |
8.44e-05 |
806 |
RESPONSE TO TEMPERATURE STIMULUS |
13 |
148 |
1.546e-05 |
8.911e-05 |
807 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
13 |
148 |
1.546e-05 |
8.911e-05 |
808 |
REGULATION OF T CELL DIFFERENTIATION |
11 |
107 |
1.597e-05 |
9.197e-05 |
809 |
TISSUE HOMEOSTASIS |
14 |
171 |
1.635e-05 |
9.405e-05 |
810 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
22 |
375 |
1.664e-05 |
9.557e-05 |
811 |
CELL FATE SPECIFICATION |
9 |
71 |
1.75e-05 |
0.0001004 |
812 |
REGULATION OF MYOTUBE DIFFERENTIATION |
8 |
55 |
1.847e-05 |
0.0001059 |
813 |
AXIS SPECIFICATION |
10 |
90 |
1.958e-05 |
0.0001121 |
814 |
NEGATIVE REGULATION OF LIPID STORAGE |
5 |
17 |
2.027e-05 |
0.0001157 |
815 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
5 |
17 |
2.027e-05 |
0.0001157 |
816 |
REGULATION OF CHROMATIN ORGANIZATION |
13 |
152 |
2.056e-05 |
0.0001173 |
817 |
REGULATION OF LIPID STORAGE |
7 |
41 |
2.111e-05 |
0.0001195 |
818 |
AORTA DEVELOPMENT |
7 |
41 |
2.111e-05 |
0.0001195 |
819 |
REGULATION OF B CELL MEDIATED IMMUNITY |
7 |
41 |
2.111e-05 |
0.0001195 |
820 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
7 |
41 |
2.111e-05 |
0.0001195 |
821 |
PROSTATE GLAND DEVELOPMENT |
7 |
41 |
2.111e-05 |
0.0001195 |
822 |
LUNG ALVEOLUS DEVELOPMENT |
7 |
41 |
2.111e-05 |
0.0001195 |
823 |
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
6 |
28 |
2.135e-05 |
0.0001206 |
824 |
MUSCLE HYPERTROPHY |
6 |
28 |
2.135e-05 |
0.0001206 |
825 |
PROTEIN STABILIZATION |
12 |
131 |
2.15e-05 |
0.0001213 |
826 |
DORSAL VENTRAL PATTERN FORMATION |
10 |
91 |
2.16e-05 |
0.0001214 |
827 |
ENSHEATHMENT OF NEURONS |
10 |
91 |
2.16e-05 |
0.0001214 |
828 |
AXON ENSHEATHMENT |
10 |
91 |
2.16e-05 |
0.0001214 |
829 |
ERYTHROCYTE HOMEOSTASIS |
9 |
73 |
2.198e-05 |
0.0001232 |
830 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
9 |
73 |
2.198e-05 |
0.0001232 |
831 |
POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY |
12 |
132 |
2.321e-05 |
0.0001299 |
832 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
15 |
200 |
2.331e-05 |
0.0001304 |
833 |
REGULATION OF MULTI ORGANISM PROCESS |
25 |
470 |
2.36e-05 |
0.0001318 |
834 |
CELLULAR LIPID METABOLIC PROCESS |
39 |
913 |
2.364e-05 |
0.0001319 |
835 |
NEGATIVE REGULATION OF HORMONE SECRETION |
9 |
74 |
2.456e-05 |
0.0001366 |
836 |
REGULATION OF STEROID METABOLIC PROCESS |
9 |
74 |
2.456e-05 |
0.0001366 |
837 |
CELL CELL JUNCTION ASSEMBLY |
9 |
74 |
2.456e-05 |
0.0001366 |
838 |
EAR MORPHOGENESIS |
11 |
112 |
2.463e-05 |
0.0001367 |
839 |
PITUITARY GLAND DEVELOPMENT |
7 |
42 |
2.487e-05 |
0.000138 |
840 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
6 |
29 |
2.645e-05 |
0.0001465 |
841 |
LIPID METABOLIC PROCESS |
46 |
1158 |
2.672e-05 |
0.0001478 |
842 |
PROTEIN LOCALIZATION TO NUCLEUS |
13 |
156 |
2.71e-05 |
0.0001497 |
843 |
OVULATION |
5 |
18 |
2.758e-05 |
0.0001512 |
844 |
REGULATION OF INTERLEUKIN 1 PRODUCTION |
8 |
58 |
2.752e-05 |
0.0001512 |
845 |
CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS |
5 |
18 |
2.758e-05 |
0.0001512 |
846 |
RESPONSE TO CAFFEINE |
5 |
18 |
2.758e-05 |
0.0001512 |
847 |
REGULATION OF HORMONE BIOSYNTHETIC PROCESS |
5 |
18 |
2.758e-05 |
0.0001512 |
848 |
BIOMINERAL TISSUE DEVELOPMENT |
9 |
75 |
2.74e-05 |
0.0001512 |
849 |
POSITIVE REGULATION OF CELL CYCLE |
20 |
332 |
2.759e-05 |
0.0001512 |
850 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
15 |
203 |
2.775e-05 |
0.0001519 |
851 |
HEXOSE METABOLIC PROCESS |
13 |
157 |
2.899e-05 |
0.0001585 |
852 |
RESPONSE TO COLD |
7 |
43 |
2.918e-05 |
0.0001588 |
853 |
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
7 |
43 |
2.918e-05 |
0.0001588 |
854 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
7 |
43 |
2.918e-05 |
0.0001588 |
855 |
CELL FATE DETERMINATION |
7 |
43 |
2.918e-05 |
0.0001588 |
856 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
15 |
204 |
2.939e-05 |
0.0001598 |
857 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
12 |
136 |
3.127e-05 |
0.0001698 |
858 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
6 |
30 |
3.248e-05 |
0.0001761 |
859 |
CIRCADIAN RHYTHM |
12 |
137 |
3.364e-05 |
0.000182 |
860 |
HINDBRAIN DEVELOPMENT |
12 |
137 |
3.364e-05 |
0.000182 |
861 |
MYELOID CELL DEVELOPMENT |
7 |
44 |
3.408e-05 |
0.0001837 |
862 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
7 |
44 |
3.408e-05 |
0.0001837 |
863 |
ENDOCRINE PROCESS |
7 |
44 |
3.408e-05 |
0.0001837 |
864 |
MAINTENANCE OF LOCATION IN CELL |
10 |
96 |
3.453e-05 |
0.0001857 |
865 |
POSITIVE REGULATION OF CYTOKINE SECRETION |
10 |
96 |
3.453e-05 |
0.0001857 |
866 |
SECOND MESSENGER MEDIATED SIGNALING |
13 |
160 |
3.537e-05 |
0.0001901 |
867 |
RESPONSE TO MUSCLE STRETCH |
5 |
19 |
3.678e-05 |
0.0001958 |
868 |
CELLULAR RESPONSE TO FLUID SHEAR STRESS |
5 |
19 |
3.678e-05 |
0.0001958 |
869 |
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
5 |
19 |
3.678e-05 |
0.0001958 |
870 |
NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
5 |
19 |
3.678e-05 |
0.0001958 |
871 |
GAS TRANSPORT |
5 |
19 |
3.678e-05 |
0.0001958 |
872 |
NEGATIVE REGULATION OF ATP METABOLIC PROCESS |
5 |
19 |
3.678e-05 |
0.0001958 |
873 |
ENTEROENDOCRINE CELL DIFFERENTIATION |
5 |
19 |
3.678e-05 |
0.0001958 |
874 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
5 |
19 |
3.678e-05 |
0.0001958 |
875 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
14 |
184 |
3.707e-05 |
0.0001971 |
876 |
ANATOMICAL STRUCTURE HOMEOSTASIS |
18 |
285 |
3.741e-05 |
0.0001987 |
877 |
LYMPHOCYTE COSTIMULATION |
9 |
78 |
3.764e-05 |
0.0001997 |
878 |
REGULATION OF CALCIUM ION TRANSPORT |
15 |
209 |
3.892e-05 |
0.000206 |
879 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
15 |
209 |
3.892e-05 |
0.000206 |
880 |
CARDIAC ATRIUM DEVELOPMENT |
6 |
31 |
3.956e-05 |
0.0002087 |
881 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
6 |
31 |
3.956e-05 |
0.0002087 |
882 |
REGULATION OF PLATELET ACTIVATION |
6 |
31 |
3.956e-05 |
0.0002087 |
883 |
ENDOTHELIAL CELL DEVELOPMENT |
7 |
45 |
3.963e-05 |
0.0002088 |
884 |
MEMBRANE DEPOLARIZATION |
8 |
61 |
4.002e-05 |
0.0002102 |
885 |
EMBRYONIC DIGIT MORPHOGENESIS |
8 |
61 |
4.002e-05 |
0.0002102 |
886 |
REGULATION OF INTERLEUKIN 8 PRODUCTION |
8 |
61 |
4.002e-05 |
0.0002102 |
887 |
MESODERM DEVELOPMENT |
11 |
118 |
4.012e-05 |
0.0002105 |
888 |
MEMORY |
10 |
98 |
4.13e-05 |
0.0002157 |
889 |
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION |
10 |
98 |
4.13e-05 |
0.0002157 |
890 |
MYELOID LEUKOCYTE ACTIVATION |
10 |
98 |
4.13e-05 |
0.0002157 |
891 |
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE |
10 |
98 |
4.13e-05 |
0.0002157 |
892 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
9 |
79 |
4.17e-05 |
0.000217 |
893 |
NEGATIVE REGULATION OF PROTEIN BINDING |
9 |
79 |
4.17e-05 |
0.000217 |
894 |
BONE MORPHOGENESIS |
9 |
79 |
4.17e-05 |
0.000217 |
895 |
ADAPTIVE IMMUNE RESPONSE |
18 |
288 |
4.289e-05 |
0.000223 |
896 |
REGULATION OF NUCLEAR DIVISION |
13 |
163 |
4.296e-05 |
0.0002231 |
897 |
SKIN DEVELOPMENT |
15 |
211 |
4.344e-05 |
0.0002253 |
898 |
FOREBRAIN CELL MIGRATION |
8 |
62 |
4.512e-05 |
0.0002338 |
899 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
7 |
46 |
4.59e-05 |
0.0002376 |
900 |
REGULATION OF ORGAN FORMATION |
6 |
32 |
4.783e-05 |
0.0002467 |
901 |
EMBRYONIC FORELIMB MORPHOGENESIS |
6 |
32 |
4.783e-05 |
0.0002467 |
902 |
METANEPHRIC NEPHRON DEVELOPMENT |
6 |
32 |
4.783e-05 |
0.0002467 |
903 |
METENCEPHALON DEVELOPMENT |
10 |
100 |
4.918e-05 |
0.0002531 |
904 |
LIMBIC SYSTEM DEVELOPMENT |
10 |
100 |
4.918e-05 |
0.0002531 |
905 |
REGULATION OF OSTEOCLAST DIFFERENTIATION |
8 |
63 |
5.074e-05 |
0.0002606 |
906 |
REGULATION OF MUSCLE ADAPTATION |
8 |
63 |
5.074e-05 |
0.0002606 |
907 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
9 |
81 |
5.094e-05 |
0.0002613 |
908 |
RAS PROTEIN SIGNAL TRANSDUCTION |
12 |
143 |
5.133e-05 |
0.000263 |
909 |
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
7 |
47 |
5.297e-05 |
0.0002708 |
910 |
REGULATION OF IMMUNOGLOBULIN PRODUCTION |
7 |
47 |
5.297e-05 |
0.0002708 |
911 |
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
10 |
101 |
5.357e-05 |
0.0002736 |
912 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
12 |
144 |
5.495e-05 |
0.0002804 |
913 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
9 |
82 |
5.617e-05 |
0.0002863 |
914 |
NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
4 |
11 |
5.681e-05 |
0.0002882 |
915 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
15 |
216 |
5.68e-05 |
0.0002882 |
916 |
NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS |
4 |
11 |
5.681e-05 |
0.0002882 |
917 |
POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
4 |
11 |
5.681e-05 |
0.0002882 |
918 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
8 |
64 |
5.694e-05 |
0.0002886 |
919 |
DENDRITIC CELL DIFFERENTIATION |
6 |
33 |
5.743e-05 |
0.0002898 |
920 |
POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION |
6 |
33 |
5.743e-05 |
0.0002898 |
921 |
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT |
6 |
33 |
5.743e-05 |
0.0002898 |
922 |
RESPONSE TO VITAMIN D |
6 |
33 |
5.743e-05 |
0.0002898 |
923 |
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
10 |
102 |
5.83e-05 |
0.0002939 |
924 |
REGULATION OF BLOOD CIRCULATION |
18 |
295 |
5.855e-05 |
0.0002949 |
925 |
RESPONSE TO IONIZING RADIATION |
12 |
145 |
5.879e-05 |
0.0002956 |
926 |
REGULATION OF ADAPTIVE IMMUNE RESPONSE |
11 |
123 |
5.883e-05 |
0.0002956 |
927 |
RESPONSE TO AXON INJURY |
7 |
48 |
6.09e-05 |
0.0003057 |
928 |
REGULATION OF LIPASE ACTIVITY |
9 |
83 |
6.184e-05 |
0.0003101 |
929 |
REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS |
5 |
21 |
6.217e-05 |
0.0003107 |
930 |
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT |
5 |
21 |
6.217e-05 |
0.0003107 |
931 |
CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
5 |
21 |
6.217e-05 |
0.0003107 |
932 |
REGULATION OF METAL ION TRANSPORT |
19 |
325 |
6.524e-05 |
0.0003257 |
933 |
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY |
16 |
245 |
6.761e-05 |
0.0003372 |
934 |
ORGAN FORMATION |
6 |
34 |
6.851e-05 |
0.0003409 |
935 |
PROTEIN DESTABILIZATION |
6 |
34 |
6.851e-05 |
0.0003409 |
936 |
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
9 |
85 |
7.466e-05 |
0.0003711 |
937 |
NEGATIVE REGULATION OF PROTEOLYSIS |
19 |
329 |
7.674e-05 |
0.0003811 |
938 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
14 |
197 |
7.794e-05 |
0.0003866 |
939 |
NEGATIVE REGULATION OF ION TRANSPORT |
11 |
127 |
7.878e-05 |
0.0003904 |
940 |
REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
5 |
22 |
7.907e-05 |
0.0003906 |
941 |
EMBRYONIC PLACENTA MORPHOGENESIS |
5 |
22 |
7.907e-05 |
0.0003906 |
942 |
HISTONE H3 DEACETYLATION |
5 |
22 |
7.907e-05 |
0.0003906 |
943 |
FACE DEVELOPMENT |
7 |
50 |
7.969e-05 |
0.0003915 |
944 |
STAT CASCADE |
7 |
50 |
7.969e-05 |
0.0003915 |
945 |
RECEPTOR INTERNALIZATION |
7 |
50 |
7.969e-05 |
0.0003915 |
946 |
JAK STAT CASCADE |
7 |
50 |
7.969e-05 |
0.0003915 |
947 |
ENDODERM FORMATION |
7 |
50 |
7.969e-05 |
0.0003915 |
948 |
NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
6 |
35 |
8.122e-05 |
0.0003974 |
949 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE |
6 |
35 |
8.122e-05 |
0.0003974 |
950 |
EMBRYONIC CAMERA TYPE EYE DEVELOPMENT |
6 |
35 |
8.122e-05 |
0.0003974 |
951 |
RESPONSE TO MONOAMINE |
6 |
35 |
8.122e-05 |
0.0003974 |
952 |
POSITIVE REGULATION OF DNA REPLICATION |
9 |
86 |
8.186e-05 |
0.0004001 |
953 |
NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS |
4 |
12 |
8.38e-05 |
0.0004078 |
954 |
CARTILAGE MORPHOGENESIS |
4 |
12 |
8.38e-05 |
0.0004078 |
955 |
HEMATOPOIETIC STEM CELL DIFFERENTIATION |
4 |
12 |
8.38e-05 |
0.0004078 |
956 |
NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
4 |
12 |
8.38e-05 |
0.0004078 |
957 |
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS |
8 |
68 |
8.837e-05 |
0.0004292 |
958 |
ORGAN GROWTH |
8 |
68 |
8.837e-05 |
0.0004292 |
959 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
9 |
87 |
8.963e-05 |
0.0004322 |
960 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
9 |
87 |
8.963e-05 |
0.0004322 |
961 |
VIRAL ENTRY INTO HOST CELL |
9 |
87 |
8.963e-05 |
0.0004322 |
962 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
9 |
87 |
8.963e-05 |
0.0004322 |
963 |
MOVEMENT IN HOST ENVIRONMENT |
9 |
87 |
8.963e-05 |
0.0004322 |
964 |
ENTRY INTO HOST |
9 |
87 |
8.963e-05 |
0.0004322 |
965 |
ENTRY INTO HOST CELL |
9 |
87 |
8.963e-05 |
0.0004322 |
966 |
POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
7 |
51 |
9.071e-05 |
0.000436 |
967 |
CELLULAR RESPONSE TO FATTY ACID |
7 |
51 |
9.071e-05 |
0.000436 |
968 |
REGULATION OF INTERLEUKIN 12 PRODUCTION |
7 |
51 |
9.071e-05 |
0.000436 |
969 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
17 |
278 |
9.101e-05 |
0.0004365 |
970 |
REGULATION OF CHROMOSOME ORGANIZATION |
17 |
278 |
9.101e-05 |
0.0004365 |
971 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
10 |
108 |
9.478e-05 |
0.0004542 |
972 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
6 |
36 |
9.575e-05 |
0.0004579 |
973 |
T CELL SELECTION |
6 |
36 |
9.575e-05 |
0.0004579 |
974 |
CYTOSKELETON ORGANIZATION |
35 |
838 |
9.765e-05 |
0.0004665 |
975 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
9 |
88 |
9.801e-05 |
0.0004678 |
976 |
EPIDERMIS DEVELOPMENT |
16 |
253 |
9.863e-05 |
0.0004702 |
977 |
RESPONSE TO INCREASED OXYGEN LEVELS |
5 |
23 |
9.93e-05 |
0.0004719 |
978 |
REGULATION OF METANEPHROS DEVELOPMENT |
5 |
23 |
9.93e-05 |
0.0004719 |
979 |
RESPONSE TO HYPEROXIA |
5 |
23 |
9.93e-05 |
0.0004719 |
980 |
TISSUE REGENERATION |
7 |
52 |
0.0001029 |
0.0004888 |
981 |
CELLULAR COMPONENT DISASSEMBLY |
25 |
515 |
0.0001032 |
0.0004894 |
982 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
9 |
89 |
0.000107 |
0.0005072 |
983 |
NEURON MIGRATION |
10 |
110 |
0.0001106 |
0.0005235 |
984 |
MAINTENANCE OF CELL NUMBER |
11 |
132 |
0.0001116 |
0.0005279 |
985 |
REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
12 |
155 |
0.0001118 |
0.0005283 |
986 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
6 |
37 |
0.0001123 |
0.0005293 |
987 |
POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
6 |
37 |
0.0001123 |
0.0005293 |
988 |
HEMOSTASIS |
18 |
311 |
0.0001147 |
0.0005401 |
989 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
7 |
53 |
0.0001165 |
0.0005475 |
990 |
MESONEPHRIC TUBULE MORPHOGENESIS |
7 |
53 |
0.0001165 |
0.0005475 |
991 |
REGULATION OF CELL MATRIX ADHESION |
9 |
90 |
0.0001168 |
0.0005482 |
992 |
TYPE B PANCREATIC CELL DEVELOPMENT |
4 |
13 |
0.000119 |
0.0005533 |
993 |
LIPOPROTEIN TRANSPORT |
4 |
13 |
0.000119 |
0.0005533 |
994 |
LEFT RIGHT AXIS SPECIFICATION |
4 |
13 |
0.000119 |
0.0005533 |
995 |
CARDIOBLAST DIFFERENTIATION |
4 |
13 |
0.000119 |
0.0005533 |
996 |
NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
4 |
13 |
0.000119 |
0.0005533 |
997 |
LIPOPROTEIN LOCALIZATION |
4 |
13 |
0.000119 |
0.0005533 |
998 |
NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
4 |
13 |
0.000119 |
0.0005533 |
999 |
LYMPH VESSEL MORPHOGENESIS |
4 |
13 |
0.000119 |
0.0005533 |
1000 |
POSITIVE REGULATION OF GLUCONEOGENESIS |
4 |
13 |
0.000119 |
0.0005533 |
1001 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
13 |
0.000119 |
0.0005533 |
1002 |
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS |
11 |
133 |
0.0001194 |
0.0005541 |
1003 |
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
11 |
133 |
0.0001194 |
0.0005541 |
1004 |
ADHERENS JUNCTION ORGANIZATION |
8 |
71 |
0.0001204 |
0.000558 |
1005 |
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
5 |
24 |
0.0001233 |
0.0005673 |
1006 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
5 |
24 |
0.0001233 |
0.0005673 |
1007 |
AXON REGENERATION |
5 |
24 |
0.0001233 |
0.0005673 |
1008 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
5 |
24 |
0.0001233 |
0.0005673 |
1009 |
REGULATION OF ODONTOGENESIS |
5 |
24 |
0.0001233 |
0.0005673 |
1010 |
REGULATION OF ISOTYPE SWITCHING |
5 |
24 |
0.0001233 |
0.0005673 |
1011 |
POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY |
5 |
24 |
0.0001233 |
0.0005673 |
1012 |
INTERACTION WITH HOST |
11 |
134 |
0.0001277 |
0.0005872 |
1013 |
RESPONSE TO TESTOSTERONE |
6 |
38 |
0.000131 |
0.000601 |
1014 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
6 |
38 |
0.000131 |
0.000601 |
1015 |
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS |
7 |
54 |
0.0001314 |
0.000602 |
1016 |
ALPHA BETA T CELL ACTIVATION |
7 |
54 |
0.0001314 |
0.000602 |
1017 |
HORMONE MEDIATED SIGNALING PATHWAY |
12 |
158 |
0.0001342 |
0.0006139 |
1018 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
11 |
135 |
0.0001365 |
0.0006237 |
1019 |
POSITIVE REGULATION OF INFLAMMATORY RESPONSE |
10 |
113 |
0.0001385 |
0.0006323 |
1020 |
REGULATION OF CELL CYCLE PROCESS |
26 |
558 |
0.0001453 |
0.0006627 |
1021 |
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE |
8 |
73 |
0.0001467 |
0.0006684 |
1022 |
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
10 |
114 |
0.000149 |
0.0006783 |
1023 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
9 |
93 |
0.0001505 |
0.0006843 |
1024 |
EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS |
5 |
25 |
0.0001514 |
0.0006881 |
1025 |
LONG TERM SYNAPTIC POTENTIATION |
6 |
39 |
0.0001521 |
0.000689 |
1026 |
NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION |
6 |
39 |
0.0001521 |
0.000689 |
1027 |
EMBRYO IMPLANTATION |
6 |
39 |
0.0001521 |
0.000689 |
1028 |
POSITIVE REGULATION OF ION TRANSPORT |
15 |
236 |
0.000153 |
0.0006925 |
1029 |
REGULATION OF DNA REPLICATION |
12 |
161 |
0.0001602 |
0.0007245 |
1030 |
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS |
8 |
74 |
0.0001615 |
0.0007294 |
1031 |
REGULATION OF MITOTIC CELL CYCLE |
23 |
468 |
0.0001623 |
0.0007326 |
1032 |
POSITIVE REGULATION OF CHOLESTEROL EFFLUX |
4 |
14 |
0.0001639 |
0.0007339 |
1033 |
POSITIVE REGULATION OF URINE VOLUME |
4 |
14 |
0.0001639 |
0.0007339 |
1034 |
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
9 |
94 |
0.0001633 |
0.0007339 |
1035 |
HEART TRABECULA FORMATION |
4 |
14 |
0.0001639 |
0.0007339 |
1036 |
REGULATION OF PROTEIN KINASE C SIGNALING |
4 |
14 |
0.0001639 |
0.0007339 |
1037 |
ANGIOGENESIS INVOLVED IN WOUND HEALING |
4 |
14 |
0.0001639 |
0.0007339 |
1038 |
MIDGUT DEVELOPMENT |
4 |
14 |
0.0001639 |
0.0007339 |
1039 |
POST EMBRYONIC ORGAN DEVELOPMENT |
4 |
14 |
0.0001639 |
0.0007339 |
1040 |
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
6 |
40 |
0.0001758 |
0.0007848 |
1041 |
DEVELOPMENTAL PIGMENTATION |
6 |
40 |
0.0001758 |
0.0007848 |
1042 |
HINDBRAIN MORPHOGENESIS |
6 |
40 |
0.0001758 |
0.0007848 |
1043 |
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
11 |
139 |
0.0001768 |
0.0007878 |
1044 |
REGULATION OF CELL SHAPE |
11 |
139 |
0.0001768 |
0.0007878 |
1045 |
SENSORY PERCEPTION OF PAIN |
8 |
75 |
0.0001775 |
0.0007895 |
1046 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
8 |
75 |
0.0001775 |
0.0007895 |
1047 |
DEVELOPMENTAL PROGRAMMED CELL DEATH |
5 |
26 |
0.0001843 |
0.0008151 |
1048 |
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY |
5 |
26 |
0.0001843 |
0.0008151 |
1049 |
REGULATION OF NECROTIC CELL DEATH |
5 |
26 |
0.0001843 |
0.0008151 |
1050 |
POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE |
5 |
26 |
0.0001843 |
0.0008151 |
1051 |
REGULATION OF P38MAPK CASCADE |
5 |
26 |
0.0001843 |
0.0008151 |
1052 |
CELLULAR RESPONSE TO VITAMIN |
5 |
26 |
0.0001843 |
0.0008151 |
1053 |
LEUKOCYTE CHEMOTAXIS |
10 |
117 |
0.0001847 |
0.000816 |
1054 |
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
7 |
57 |
0.0001859 |
0.0008206 |
1055 |
REGULATION OF SYNAPTIC PLASTICITY |
11 |
140 |
0.0001883 |
0.0008303 |
1056 |
NEGATIVE REGULATION OF WOUND HEALING |
7 |
58 |
0.0002076 |
0.0009148 |
1057 |
GLUCOSE METABOLIC PROCESS |
10 |
119 |
0.0002122 |
0.0009343 |
1058 |
PLATELET ACTIVATION |
11 |
142 |
0.0002132 |
0.0009368 |
1059 |
DETOXIFICATION |
8 |
77 |
0.0002134 |
0.0009368 |
1060 |
DEVELOPMENTAL CELL GROWTH |
8 |
77 |
0.0002134 |
0.0009368 |
1061 |
RESPONSE TO MURAMYL DIPEPTIDE |
4 |
15 |
0.0002198 |
0.0009593 |
1062 |
INTERLEUKIN 1 PRODUCTION |
4 |
15 |
0.0002198 |
0.0009593 |
1063 |
NEGATIVE REGULATION OF HISTONE ACETYLATION |
4 |
15 |
0.0002198 |
0.0009593 |
1064 |
ENDOCARDIAL CUSHION FORMATION |
4 |
15 |
0.0002198 |
0.0009593 |
1065 |
OXYGEN TRANSPORT |
4 |
15 |
0.0002198 |
0.0009593 |
1066 |
NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION |
4 |
15 |
0.0002198 |
0.0009593 |
1067 |
NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION |
5 |
27 |
0.0002223 |
0.0009657 |
1068 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
5 |
27 |
0.0002223 |
0.0009657 |
1069 |
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS |
5 |
27 |
0.0002223 |
0.0009657 |
1070 |
AXIS ELONGATION |
5 |
27 |
0.0002223 |
0.0009657 |
1071 |
POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS |
5 |
27 |
0.0002223 |
0.0009657 |
1072 |
REGULATION OF DENDRITE DEVELOPMENT |
10 |
120 |
0.0002273 |
0.0009865 |
1073 |
REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
6 |
42 |
0.0002318 |
0.001002 |
1074 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
6 |
42 |
0.0002318 |
0.001002 |
1075 |
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
6 |
42 |
0.0002318 |
0.001002 |
1076 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
6 |
42 |
0.0002318 |
0.001002 |
1077 |
EPITHELIAL CELL MORPHOGENESIS |
6 |
42 |
0.0002318 |
0.001002 |
1078 |
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE |
15 |
246 |
0.0002403 |
0.001037 |
1079 |
LIPID PHOSPHORYLATION |
9 |
99 |
0.0002424 |
0.001045 |
1080 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
16 |
274 |
0.0002459 |
0.001059 |
1081 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
23 |
482 |
0.0002482 |
0.001068 |
1082 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
15 |
247 |
0.000251 |
0.001079 |
1083 |
REGULATION OF GLUCOSE IMPORT |
7 |
60 |
0.0002572 |
0.001103 |
1084 |
OLIGODENDROCYTE DIFFERENTIATION |
7 |
60 |
0.0002572 |
0.001103 |
1085 |
LEUKOCYTE HOMEOSTASIS |
7 |
60 |
0.0002572 |
0.001103 |
1086 |
MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM |
9 |
100 |
0.0002615 |
0.00112 |
1087 |
DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM |
6 |
43 |
0.0002647 |
0.001133 |
1088 |
PLACENTA BLOOD VESSEL DEVELOPMENT |
5 |
28 |
0.000266 |
0.001135 |
1089 |
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER |
5 |
28 |
0.000266 |
0.001135 |
1090 |
REGULATION OF FATTY ACID OXIDATION |
5 |
28 |
0.000266 |
0.001135 |
1091 |
REGULATION OF AUTOPHAGY |
15 |
249 |
0.0002737 |
0.001167 |
1092 |
ADULT LOCOMOTORY BEHAVIOR |
8 |
80 |
0.0002783 |
0.001186 |
1093 |
NOTCH RECEPTOR PROCESSING |
4 |
16 |
0.0002882 |
0.001215 |
1094 |
REGULATION OF MUSCLE CONTRACTION |
11 |
147 |
0.0002881 |
0.001215 |
1095 |
REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
4 |
16 |
0.0002882 |
0.001215 |
1096 |
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION |
4 |
16 |
0.0002882 |
0.001215 |
1097 |
ORGAN INDUCTION |
4 |
16 |
0.0002882 |
0.001215 |
1098 |
NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT |
4 |
16 |
0.0002882 |
0.001215 |
1099 |
NEGATIVE REGULATION OF CHEMOKINE PRODUCTION |
4 |
16 |
0.0002882 |
0.001215 |
1100 |
RESPONSE TO EPINEPHRINE |
4 |
16 |
0.0002882 |
0.001215 |
1101 |
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS |
4 |
16 |
0.0002882 |
0.001215 |
1102 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
4 |
16 |
0.0002882 |
0.001215 |
1103 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
4 |
16 |
0.0002882 |
0.001215 |
1104 |
MONOCYTE DIFFERENTIATION |
4 |
16 |
0.0002882 |
0.001215 |
1105 |
LABYRINTHINE LAYER DEVELOPMENT |
6 |
44 |
0.0003011 |
0.001265 |
1106 |
BODY MORPHOGENESIS |
6 |
44 |
0.0003011 |
0.001265 |
1107 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
6 |
44 |
0.0003011 |
0.001265 |
1108 |
NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
6 |
44 |
0.0003011 |
0.001265 |
1109 |
REGULATION OF JUN KINASE ACTIVITY |
8 |
81 |
0.0003032 |
0.001272 |
1110 |
RENAL SYSTEM PROCESS |
9 |
102 |
0.0003035 |
0.001272 |
1111 |
REGULATION OF TRANSPORTER ACTIVITY |
13 |
198 |
0.0003038 |
0.001272 |
1112 |
ACTIVATION OF IMMUNE RESPONSE |
21 |
427 |
0.000307 |
0.001284 |
1113 |
SIGNAL RELEASE |
12 |
173 |
0.0003122 |
0.001305 |
1114 |
EPIDERMIS MORPHOGENESIS |
5 |
29 |
0.0003159 |
0.001315 |
1115 |
RESPONSE TO PAIN |
5 |
29 |
0.0003159 |
0.001315 |
1116 |
PIGMENT CELL DIFFERENTIATION |
5 |
29 |
0.0003159 |
0.001315 |
1117 |
POSITIVE REGULATION OF NUCLEAR DIVISION |
7 |
62 |
0.000316 |
0.001315 |
1118 |
POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION |
5 |
29 |
0.0003159 |
0.001315 |
1119 |
ALPHA BETA T CELL DIFFERENTIATION |
6 |
45 |
0.0003413 |
0.001418 |
1120 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL |
6 |
45 |
0.0003413 |
0.001418 |
1121 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
7 |
63 |
0.0003491 |
0.001448 |
1122 |
RESPONSE TO OSMOTIC STRESS |
7 |
63 |
0.0003491 |
0.001448 |
1123 |
NEGATIVE REGULATION OF MULTI ORGANISM PROCESS |
11 |
151 |
0.000363 |
0.001504 |
1124 |
MONOSACCHARIDE METABOLIC PROCESS |
13 |
202 |
0.0003684 |
0.001525 |
1125 |
NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
4 |
17 |
0.0003706 |
0.001526 |
1126 |
POSITIVE REGULATION OF STEROL TRANSPORT |
4 |
17 |
0.0003706 |
0.001526 |
1127 |
REGULATION OF ENERGY HOMEOSTASIS |
4 |
17 |
0.0003706 |
0.001526 |
1128 |
POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS |
4 |
17 |
0.0003706 |
0.001526 |
1129 |
NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
4 |
17 |
0.0003706 |
0.001526 |
1130 |
POSITIVE REGULATION OF CHOLESTEROL TRANSPORT |
4 |
17 |
0.0003706 |
0.001526 |
1131 |
CEREBELLAR CORTEX MORPHOGENESIS |
5 |
30 |
0.0003725 |
0.001531 |
1132 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
5 |
30 |
0.0003725 |
0.001531 |
1133 |
REGULATION OF INTERLEUKIN 10 PRODUCTION |
6 |
46 |
0.0003857 |
0.00158 |
1134 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
7 |
64 |
0.000385 |
0.00158 |
1135 |
NEGATIVE REGULATION OF CYTOKINE SECRETION |
6 |
46 |
0.0003857 |
0.00158 |
1136 |
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
7 |
64 |
0.000385 |
0.00158 |
1137 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
8 |
84 |
0.0003891 |
0.001593 |
1138 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
9 |
106 |
0.0004043 |
0.001653 |
1139 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
11 |
153 |
0.0004062 |
0.001659 |
1140 |
REGULATION OF CAMP METABOLIC PROCESS |
10 |
129 |
0.0004074 |
0.001663 |
1141 |
PALATE DEVELOPMENT |
8 |
85 |
0.0004218 |
0.00172 |
1142 |
MUSCLE FIBER DEVELOPMENT |
6 |
47 |
0.0004343 |
0.001765 |
1143 |
POSITIVE REGULATION OF DEPHOSPHORYLATION |
6 |
47 |
0.0004343 |
0.001765 |
1144 |
PRIMARY ALCOHOL METABOLIC PROCESS |
6 |
47 |
0.0004343 |
0.001765 |
1145 |
POSITIVE REGULATION OF GLIOGENESIS |
6 |
47 |
0.0004343 |
0.001765 |
1146 |
HYALURONAN METABOLIC PROCESS |
5 |
31 |
0.0004366 |
0.001768 |
1147 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
5 |
31 |
0.0004366 |
0.001768 |
1148 |
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION |
5 |
31 |
0.0004366 |
0.001768 |
1149 |
LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY |
5 |
31 |
0.0004366 |
0.001768 |
1150 |
ALCOHOL METABOLIC PROCESS |
18 |
348 |
0.0004514 |
0.001826 |
1151 |
PIGMENTATION |
8 |
86 |
0.0004567 |
0.001846 |
1152 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
10 |
131 |
0.0004605 |
0.00186 |
1153 |
VIRAL LIFE CYCLE |
16 |
290 |
0.0004611 |
0.001861 |
1154 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
4 |
18 |
0.0004686 |
0.00187 |
1155 |
ORGAN MATURATION |
4 |
18 |
0.0004686 |
0.00187 |
1156 |
GLANDULAR EPITHELIAL CELL DEVELOPMENT |
4 |
18 |
0.0004686 |
0.00187 |
1157 |
RESPONSE TO PLATELET DERIVED GROWTH FACTOR |
4 |
18 |
0.0004686 |
0.00187 |
1158 |
MESODERM MORPHOGENESIS |
7 |
66 |
0.0004656 |
0.00187 |
1159 |
PERICARDIUM DEVELOPMENT |
4 |
18 |
0.0004686 |
0.00187 |
1160 |
OSTEOBLAST DEVELOPMENT |
4 |
18 |
0.0004686 |
0.00187 |
1161 |
POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS |
7 |
66 |
0.0004656 |
0.00187 |
1162 |
NOTOCHORD DEVELOPMENT |
4 |
18 |
0.0004686 |
0.00187 |
1163 |
MUSCLE CELL MIGRATION |
4 |
18 |
0.0004686 |
0.00187 |
1164 |
POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY |
4 |
18 |
0.0004686 |
0.00187 |
1165 |
RESPONSE TO WATER |
4 |
18 |
0.0004686 |
0.00187 |
1166 |
UTERUS DEVELOPMENT |
4 |
18 |
0.0004686 |
0.00187 |
1167 |
LOCOMOTORY BEHAVIOR |
12 |
181 |
0.0004704 |
0.001876 |
1168 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
15 |
263 |
0.000488 |
0.001939 |
1169 |
NEGATIVE REGULATION OF COAGULATION |
6 |
48 |
0.0004877 |
0.001939 |
1170 |
MYOFIBRIL ASSEMBLY |
6 |
48 |
0.0004877 |
0.001939 |
1171 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT |
6 |
48 |
0.0004877 |
0.001939 |
1172 |
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
9 |
109 |
0.0004967 |
0.00197 |
1173 |
POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
9 |
109 |
0.0004967 |
0.00197 |
1174 |
NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
5 |
32 |
0.0005085 |
0.002009 |
1175 |
POSITIVE REGULATION OF VASODILATION |
5 |
32 |
0.0005085 |
0.002009 |
1176 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA |
5 |
32 |
0.0005085 |
0.002009 |
1177 |
REGULATION OF ACTIN CYTOSKELETON REORGANIZATION |
5 |
32 |
0.0005085 |
0.002009 |
1178 |
PEPTIDE HORMONE PROCESSING |
5 |
32 |
0.0005085 |
0.002009 |
1179 |
REGULATION OF NOTCH SIGNALING PATHWAY |
7 |
67 |
0.0005107 |
0.002012 |
1180 |
CELL AGING |
7 |
67 |
0.0005107 |
0.002012 |
1181 |
CELLULAR RESPONSE TO DRUG |
7 |
67 |
0.0005107 |
0.002012 |
1182 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
17 |
323 |
0.0005303 |
0.002088 |
1183 |
LEUKOCYTE PROLIFERATION |
8 |
88 |
0.0005334 |
0.002096 |
1184 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
8 |
88 |
0.0005334 |
0.002096 |
1185 |
NEGATIVE REGULATION OF PEPTIDE SECRETION |
6 |
49 |
0.000546 |
0.002139 |
1186 |
REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
6 |
49 |
0.000546 |
0.002139 |
1187 |
POSITIVE REGULATION OF CHEMOKINE PRODUCTION |
6 |
49 |
0.000546 |
0.002139 |
1188 |
REGULATION OF ATP METABOLIC PROCESS |
6 |
49 |
0.000546 |
0.002139 |
1189 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
10 |
134 |
0.0005507 |
0.002155 |
1190 |
REGULATION OF ALPHA BETA T CELL ACTIVATION |
7 |
68 |
0.0005591 |
0.002181 |
1191 |
REGULATION OF CELL JUNCTION ASSEMBLY |
7 |
68 |
0.0005591 |
0.002181 |
1192 |
REGULATION OF NEUROLOGICAL SYSTEM PROCESS |
7 |
68 |
0.0005591 |
0.002181 |
1193 |
POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION |
7 |
68 |
0.0005591 |
0.002181 |
1194 |
ADULT BEHAVIOR |
10 |
135 |
0.0005838 |
0.002268 |
1195 |
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
19 |
0.0005838 |
0.002268 |
1196 |
FIBRIL ORGANIZATION |
4 |
19 |
0.0005838 |
0.002268 |
1197 |
NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION |
4 |
19 |
0.0005838 |
0.002268 |
1198 |
CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES |
4 |
19 |
0.0005838 |
0.002268 |
1199 |
NEGATIVE REGULATION OF ANION TRANSPORT |
5 |
33 |
0.0005891 |
0.002286 |
1200 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
7 |
69 |
0.0006112 |
0.002368 |
1201 |
POSITIVE REGULATION OF AXONOGENESIS |
7 |
69 |
0.0006112 |
0.002368 |
1202 |
EYE MORPHOGENESIS |
10 |
136 |
0.0006186 |
0.002395 |
1203 |
REGULATION OF GLIOGENESIS |
8 |
90 |
0.0006203 |
0.002399 |
1204 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
21 |
452 |
0.0006455 |
0.002495 |
1205 |
CELLULAR RESPONSE TO RADIATION |
10 |
137 |
0.0006551 |
0.00253 |
1206 |
MUSCLE ORGAN MORPHOGENESIS |
7 |
70 |
0.000667 |
0.002573 |
1207 |
POSITIVE REGULATION OF LIPID TRANSPORT |
6 |
51 |
0.0006788 |
0.002602 |
1208 |
CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
5 |
34 |
0.0006789 |
0.002602 |
1209 |
RESPONSE TO NICOTINE |
6 |
51 |
0.0006788 |
0.002602 |
1210 |
NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
6 |
51 |
0.0006788 |
0.002602 |
1211 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
5 |
34 |
0.0006789 |
0.002602 |
1212 |
OLIGODENDROCYTE DEVELOPMENT |
5 |
34 |
0.0006789 |
0.002602 |
1213 |
CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS |
6 |
51 |
0.0006788 |
0.002602 |
1214 |
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION |
6 |
51 |
0.0006788 |
0.002602 |
1215 |
IMMUNE EFFECTOR PROCESS |
22 |
486 |
0.000683 |
0.002615 |
1216 |
REGULATION OF ANION TRANSPORT |
10 |
138 |
0.0006933 |
0.002653 |
1217 |
HYDROGEN PEROXIDE CATABOLIC PROCESS |
4 |
20 |
0.0007177 |
0.002724 |
1218 |
REGULATION OF CHOLESTEROL EFFLUX |
4 |
20 |
0.0007177 |
0.002724 |
1219 |
REGULATION OF URINE VOLUME |
4 |
20 |
0.0007177 |
0.002724 |
1220 |
TRACHEA DEVELOPMENT |
4 |
20 |
0.0007177 |
0.002724 |
1221 |
POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
4 |
20 |
0.0007177 |
0.002724 |
1222 |
RESPONSE TO VITAMIN A |
4 |
20 |
0.0007177 |
0.002724 |
1223 |
MEGAKARYOCYTE DIFFERENTIATION |
4 |
20 |
0.0007177 |
0.002724 |
1224 |
REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT |
4 |
20 |
0.0007177 |
0.002724 |
1225 |
LYMPH VESSEL DEVELOPMENT |
4 |
20 |
0.0007177 |
0.002724 |
1226 |
MYELOID DENDRITIC CELL DIFFERENTIATION |
4 |
20 |
0.0007177 |
0.002724 |
1227 |
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
7 |
71 |
0.0007268 |
0.002754 |
1228 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING |
7 |
71 |
0.0007268 |
0.002754 |
1229 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
34 |
898 |
0.0007287 |
0.002759 |
1230 |
INTERACTION WITH SYMBIONT |
6 |
52 |
0.0007539 |
0.002852 |
1231 |
NON CANONICAL WNT SIGNALING PATHWAY |
10 |
140 |
0.0007753 |
0.00293 |
1232 |
NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION |
5 |
35 |
0.0007785 |
0.002931 |
1233 |
BONE REMODELING |
5 |
35 |
0.0007785 |
0.002931 |
1234 |
REGULATION OF GLYCOGEN METABOLIC PROCESS |
5 |
35 |
0.0007785 |
0.002931 |
1235 |
RESPONSE TO MINERALOCORTICOID |
5 |
35 |
0.0007785 |
0.002931 |
1236 |
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES |
5 |
35 |
0.0007785 |
0.002931 |
1237 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
9 |
116 |
0.0007809 |
0.002937 |
1238 |
DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM |
7 |
72 |
0.0007907 |
0.002969 |
1239 |
SMOOTHENED SIGNALING PATHWAY |
7 |
72 |
0.0007907 |
0.002969 |
1240 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
12 |
192 |
0.0007941 |
0.00298 |
1241 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
11 |
166 |
0.0008051 |
0.003019 |
1242 |
REGULATION OF DNA BIOSYNTHETIC PROCESS |
8 |
94 |
0.0008283 |
0.003103 |
1243 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
6 |
53 |
0.0008353 |
0.003124 |
1244 |
SKELETAL MUSCLE CELL DIFFERENTIATION |
6 |
53 |
0.0008353 |
0.003124 |
1245 |
REGULATION OF HEART CONTRACTION |
13 |
221 |
0.0008582 |
0.003207 |
1246 |
REGULATION OF PLASMA MEMBRANE ORGANIZATION |
7 |
73 |
0.000859 |
0.003208 |
1247 |
RESPONSE TO DIETARY EXCESS |
4 |
21 |
0.0008719 |
0.003235 |
1248 |
DECIDUALIZATION |
4 |
21 |
0.0008719 |
0.003235 |
1249 |
LEFT RIGHT PATTERN FORMATION |
4 |
21 |
0.0008719 |
0.003235 |
1250 |
POSITIVE T CELL SELECTION |
4 |
21 |
0.0008719 |
0.003235 |
1251 |
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
4 |
21 |
0.0008719 |
0.003235 |
1252 |
NEGATIVE REGULATION OF PROTEIN ACETYLATION |
4 |
21 |
0.0008719 |
0.003235 |
1253 |
EPITHELIAL STRUCTURE MAINTENANCE |
4 |
21 |
0.0008719 |
0.003235 |
1254 |
RESPONSE TO NITRIC OXIDE |
4 |
21 |
0.0008719 |
0.003235 |
1255 |
REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
5 |
36 |
0.0008886 |
0.003284 |
1256 |
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
8 |
95 |
0.0008882 |
0.003284 |
1257 |
POSITIVE REGULATION OF PROTEIN ACETYLATION |
5 |
36 |
0.0008886 |
0.003284 |
1258 |
REGULATION OF AXONOGENESIS |
11 |
168 |
0.0008886 |
0.003284 |
1259 |
HEAD MORPHOGENESIS |
5 |
36 |
0.0008886 |
0.003284 |
1260 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
10 |
143 |
0.0009131 |
0.003372 |
1261 |
VENTRICULAR SEPTUM DEVELOPMENT |
6 |
54 |
0.0009232 |
0.003407 |
1262 |
RESPONSE TO LIGHT STIMULUS |
15 |
280 |
0.0009279 |
0.003421 |
1263 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
74 |
0.0009319 |
0.003433 |
1264 |
NEUROLOGICAL SYSTEM PROCESS |
43 |
1242 |
0.0009363 |
0.003447 |
1265 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
9 |
119 |
0.0009377 |
0.003449 |
1266 |
REGULATION OF LEUKOCYTE CHEMOTAXIS |
8 |
96 |
0.0009515 |
0.003491 |
1267 |
FEMALE GAMETE GENERATION |
8 |
96 |
0.0009515 |
0.003491 |
1268 |
REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
8 |
96 |
0.0009515 |
0.003491 |
1269 |
POSITIVE REGULATION OF B CELL PROLIFERATION |
5 |
37 |
0.00101 |
0.003697 |
1270 |
CELLULAR GLUCOSE HOMEOSTASIS |
7 |
75 |
0.00101 |
0.003697 |
1271 |
REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
5 |
37 |
0.00101 |
0.003697 |
1272 |
REGULATION OF B CELL PROLIFERATION |
6 |
55 |
0.001018 |
0.003724 |
1273 |
RESPONSE TO IMMOBILIZATION STRESS |
4 |
22 |
0.001048 |
0.003816 |
1274 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
4 |
22 |
0.001048 |
0.003816 |
1275 |
REGULATION OF CELLULAR EXTRAVASATION |
4 |
22 |
0.001048 |
0.003816 |
1276 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN |
4 |
22 |
0.001048 |
0.003816 |
1277 |
REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
4 |
22 |
0.001048 |
0.003816 |
1278 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
4 |
22 |
0.001048 |
0.003816 |
1279 |
NEGATIVE REGULATION OF IMMUNE RESPONSE |
9 |
121 |
0.001056 |
0.003841 |
1280 |
FATTY ACID TRANSPORT |
6 |
56 |
0.00112 |
0.004073 |
1281 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
5 |
38 |
0.001143 |
0.004149 |
1282 |
CYTOKINE SECRETION |
5 |
38 |
0.001143 |
0.004149 |
1283 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
7 |
77 |
0.00118 |
0.00428 |
1284 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
10 |
148 |
0.001187 |
0.004295 |
1285 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
9 |
123 |
0.001186 |
0.004295 |
1286 |
POSITIVE REGULATION OF CELL GROWTH |
10 |
148 |
0.001187 |
0.004295 |
1287 |
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
6 |
57 |
0.00123 |
0.004445 |
1288 |
MYOTUBE DIFFERENTIATION |
6 |
57 |
0.00123 |
0.004445 |
1289 |
REGULATION OF GLUCOSE TRANSPORT |
8 |
100 |
0.001242 |
0.004482 |
1290 |
PROSTATE GLAND MORPHOGENESIS |
4 |
23 |
0.001248 |
0.004487 |
1291 |
RESPONSE TO MAGNESIUM ION |
4 |
23 |
0.001248 |
0.004487 |
1292 |
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION |
4 |
23 |
0.001248 |
0.004487 |
1293 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS |
4 |
23 |
0.001248 |
0.004487 |
1294 |
REGULATION OF SUPEROXIDE METABOLIC PROCESS |
4 |
23 |
0.001248 |
0.004487 |
1295 |
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
7 |
78 |
0.001273 |
0.004572 |
1296 |
SOMITE DEVELOPMENT |
7 |
78 |
0.001273 |
0.004572 |
1297 |
NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
5 |
39 |
0.001289 |
0.00462 |
1298 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
5 |
39 |
0.001289 |
0.00462 |
1299 |
REGULATION OF NLRP3 INFLAMMASOME COMPLEX ASSEMBLY |
3 |
11 |
0.001347 |
0.004735 |
1300 |
CARDIAC MUSCLE ADAPTATION |
3 |
11 |
0.001347 |
0.004735 |
1301 |
BONE TRABECULA MORPHOGENESIS |
3 |
11 |
0.001347 |
0.004735 |
1302 |
PRIMITIVE STREAK FORMATION |
3 |
11 |
0.001347 |
0.004735 |
1303 |
NEGATIVE REGULATION OF GLYCOLYTIC PROCESS |
3 |
11 |
0.001347 |
0.004735 |
1304 |
RESPONSE TO GRAVITY |
3 |
11 |
0.001347 |
0.004735 |
1305 |
REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
3 |
11 |
0.001347 |
0.004735 |
1306 |
ENDOCARDIUM DEVELOPMENT |
3 |
11 |
0.001347 |
0.004735 |
1307 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
13 |
232 |
0.001335 |
0.004735 |
1308 |
LYMPHANGIOGENESIS |
3 |
11 |
0.001347 |
0.004735 |
1309 |
POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
3 |
11 |
0.001347 |
0.004735 |
1310 |
ERYTHROCYTE MATURATION |
3 |
11 |
0.001347 |
0.004735 |
1311 |
MUSCLE HYPERTROPHY IN RESPONSE TO STRESS |
3 |
11 |
0.001347 |
0.004735 |
1312 |
MUSCLE ATROPHY |
3 |
11 |
0.001347 |
0.004735 |
1313 |
BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS |
3 |
11 |
0.001347 |
0.004735 |
1314 |
NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS |
3 |
11 |
0.001347 |
0.004735 |
1315 |
EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION |
3 |
11 |
0.001347 |
0.004735 |
1316 |
NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS |
3 |
11 |
0.001347 |
0.004735 |
1317 |
ACTIVATION OF INNATE IMMUNE RESPONSE |
12 |
204 |
0.001341 |
0.004735 |
1318 |
CARDIAC CHAMBER FORMATION |
3 |
11 |
0.001347 |
0.004735 |
1319 |
CAMERA TYPE EYE MORPHOGENESIS |
8 |
101 |
0.001324 |
0.004735 |
1320 |
IMMUNOLOGICAL SYNAPSE FORMATION |
3 |
11 |
0.001347 |
0.004735 |
1321 |
ENDOTHELIAL TUBE MORPHOGENESIS |
3 |
11 |
0.001347 |
0.004735 |
1322 |
REGULATION OF NECROPTOTIC PROCESS |
3 |
11 |
0.001347 |
0.004735 |
1323 |
CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS |
3 |
11 |
0.001347 |
0.004735 |
1324 |
CORPUS CALLOSUM DEVELOPMENT |
3 |
11 |
0.001347 |
0.004735 |
1325 |
REGULATION OF MEIOTIC CELL CYCLE |
5 |
40 |
0.001448 |
0.00508 |
1326 |
ENDODERMAL CELL DIFFERENTIATION |
5 |
40 |
0.001448 |
0.00508 |
1327 |
FOCAL ADHESION ASSEMBLY |
4 |
24 |
0.001473 |
0.00514 |
1328 |
HYPOTHALAMUS DEVELOPMENT |
4 |
24 |
0.001473 |
0.00514 |
1329 |
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION |
4 |
24 |
0.001473 |
0.00514 |
1330 |
SPINAL CORD PATTERNING |
4 |
24 |
0.001473 |
0.00514 |
1331 |
CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY |
4 |
24 |
0.001473 |
0.00514 |
1332 |
REGULATION OF GLIAL CELL DIFFERENTIATION |
6 |
59 |
0.001475 |
0.00514 |
1333 |
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
4 |
24 |
0.001473 |
0.00514 |
1334 |
NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
4 |
24 |
0.001473 |
0.00514 |
1335 |
REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS |
6 |
59 |
0.001475 |
0.00514 |
1336 |
INSULIN RECEPTOR SIGNALING PATHWAY |
7 |
80 |
0.001477 |
0.005145 |
1337 |
PALLIUM DEVELOPMENT |
10 |
153 |
0.001525 |
0.005306 |
1338 |
RESPONSE TO STARVATION |
10 |
154 |
0.001601 |
0.005566 |
1339 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
6 |
60 |
0.00161 |
0.005595 |
1340 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
5 |
41 |
0.001621 |
0.005607 |
1341 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
5 |
41 |
0.001621 |
0.005607 |
1342 |
CELLULAR RESPONSE TO ESTROGEN STIMULUS |
5 |
41 |
0.001621 |
0.005607 |
1343 |
MONOCYTE CHEMOTAXIS |
5 |
41 |
0.001621 |
0.005607 |
1344 |
REGULATION OF LEUKOCYTE DEGRANULATION |
5 |
41 |
0.001621 |
0.005607 |
1345 |
DEFENSE RESPONSE TO BACTERIUM |
13 |
237 |
0.001616 |
0.005607 |
1346 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
11 |
181 |
0.001623 |
0.005612 |
1347 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
7 |
82 |
0.001706 |
0.005893 |
1348 |
LENS FIBER CELL DIFFERENTIATION |
4 |
25 |
0.001724 |
0.005926 |
1349 |
CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS |
4 |
25 |
0.001724 |
0.005926 |
1350 |
POSITIVE REGULATION OF COAGULATION |
4 |
25 |
0.001724 |
0.005926 |
1351 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
4 |
25 |
0.001724 |
0.005926 |
1352 |
PROTEIN LOCALIZATION TO ORGANELLE |
23 |
556 |
0.001718 |
0.005926 |
1353 |
THYROID GLAND DEVELOPMENT |
4 |
25 |
0.001724 |
0.005926 |
1354 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
4 |
25 |
0.001724 |
0.005926 |
1355 |
REGULATION OF REGULATED SECRETORY PATHWAY |
9 |
130 |
0.001745 |
0.005991 |
1356 |
REGULATION OF TIMING OF CELL DIFFERENTIATION |
3 |
12 |
0.001769 |
0.006011 |
1357 |
ANATOMICAL STRUCTURE REGRESSION |
3 |
12 |
0.001769 |
0.006011 |
1358 |
REGULATION OF MACROPHAGE CYTOKINE PRODUCTION |
3 |
12 |
0.001769 |
0.006011 |
1359 |
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS |
3 |
12 |
0.001769 |
0.006011 |
1360 |
POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
3 |
12 |
0.001769 |
0.006011 |
1361 |
I KAPPAB PHOSPHORYLATION |
3 |
12 |
0.001769 |
0.006011 |
1362 |
REGULATION OF DEVELOPMENT HETEROCHRONIC |
3 |
12 |
0.001769 |
0.006011 |
1363 |
RENAL ABSORPTION |
3 |
12 |
0.001769 |
0.006011 |
1364 |
COLLECTING DUCT DEVELOPMENT |
3 |
12 |
0.001769 |
0.006011 |
1365 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
6 |
61 |
0.001755 |
0.006011 |
1366 |
POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION |
3 |
12 |
0.001769 |
0.006011 |
1367 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
3 |
12 |
0.001769 |
0.006011 |
1368 |
REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION |
3 |
12 |
0.001769 |
0.006011 |
1369 |
POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
3 |
12 |
0.001769 |
0.006011 |
1370 |
POLYSACCHARIDE BIOSYNTHETIC PROCESS |
5 |
42 |
0.001808 |
0.006138 |
1371 |
REGULATION OF BONE REMODELING |
5 |
42 |
0.001808 |
0.006138 |
1372 |
LEARNING |
9 |
131 |
0.001839 |
0.006238 |
1373 |
POSITIVE REGULATION OF MULTI ORGANISM PROCESS |
10 |
157 |
0.001847 |
0.006261 |
1374 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
6 |
62 |
0.001909 |
0.006455 |
1375 |
CARDIAC VENTRICLE MORPHOGENESIS |
6 |
62 |
0.001909 |
0.006455 |
1376 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
6 |
62 |
0.001909 |
0.006455 |
1377 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
8 |
107 |
0.001916 |
0.006474 |
1378 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
7 |
84 |
0.001961 |
0.006621 |
1379 |
REGULATION OF T HELPER CELL DIFFERENTIATION |
4 |
26 |
0.002004 |
0.006724 |
1380 |
REGULATION OF MESONEPHROS DEVELOPMENT |
4 |
26 |
0.002004 |
0.006724 |
1381 |
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
4 |
26 |
0.002004 |
0.006724 |
1382 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
4 |
26 |
0.002004 |
0.006724 |
1383 |
MESODERMAL CELL DIFFERENTIATION |
4 |
26 |
0.002004 |
0.006724 |
1384 |
SCHWANN CELL DEVELOPMENT |
4 |
26 |
0.002004 |
0.006724 |
1385 |
INACTIVATION OF MAPK ACTIVITY |
4 |
26 |
0.002004 |
0.006724 |
1386 |
MYELOID DENDRITIC CELL ACTIVATION |
4 |
26 |
0.002004 |
0.006724 |
1387 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
4 |
26 |
0.002004 |
0.006724 |
1388 |
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
5 |
43 |
0.002012 |
0.006744 |
1389 |
REGULATION OF EXOCYTOSIS |
11 |
186 |
0.002014 |
0.006745 |
1390 |
REGULATION OF CELL CYCLE ARREST |
8 |
108 |
0.002032 |
0.006802 |
1391 |
REGULATION OF EPIDERMIS DEVELOPMENT |
6 |
63 |
0.002073 |
0.006929 |
1392 |
POSITIVE REGULATION OF JUN KINASE ACTIVITY |
6 |
63 |
0.002073 |
0.006929 |
1393 |
TOLL LIKE RECEPTOR SIGNALING PATHWAY |
7 |
85 |
0.002099 |
0.007006 |
1394 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
7 |
85 |
0.002099 |
0.007006 |
1395 |
PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY |
8 |
109 |
0.002154 |
0.007173 |
1396 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
8 |
109 |
0.002154 |
0.007173 |
1397 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
8 |
109 |
0.002154 |
0.007173 |
1398 |
NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS |
5 |
44 |
0.002231 |
0.007415 |
1399 |
POSITIVE REGULATION OF MUSCLE CONTRACTION |
5 |
44 |
0.002231 |
0.007415 |
1400 |
NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
5 |
44 |
0.002231 |
0.007415 |
1401 |
REGULATION OF VASCULOGENESIS |
3 |
13 |
0.002264 |
0.007417 |
1402 |
NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION |
3 |
13 |
0.002264 |
0.007417 |
1403 |
MALE SEX DETERMINATION |
3 |
13 |
0.002264 |
0.007417 |
1404 |
WHITE FAT CELL DIFFERENTIATION |
3 |
13 |
0.002264 |
0.007417 |
1405 |
PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
3 |
13 |
0.002264 |
0.007417 |
1406 |
SPONGIOTROPHOBLAST LAYER DEVELOPMENT |
3 |
13 |
0.002264 |
0.007417 |
1407 |
BEHAVIORAL RESPONSE TO PAIN |
3 |
13 |
0.002264 |
0.007417 |
1408 |
RESPONSE TO INACTIVITY |
3 |
13 |
0.002264 |
0.007417 |
1409 |
EYELID DEVELOPMENT IN CAMERA TYPE EYE |
3 |
13 |
0.002264 |
0.007417 |
1410 |
HEMATOPOIETIC STEM CELL PROLIFERATION |
3 |
13 |
0.002264 |
0.007417 |
1411 |
REGULATION OF HEART RATE |
7 |
86 |
0.002245 |
0.007417 |
1412 |
HEART VALVE FORMATION |
3 |
13 |
0.002264 |
0.007417 |
1413 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
6 |
64 |
0.002248 |
0.007417 |
1414 |
NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION |
3 |
13 |
0.002264 |
0.007417 |
1415 |
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY |
3 |
13 |
0.002264 |
0.007417 |
1416 |
REGULATION OF CHOLESTEROL STORAGE |
3 |
13 |
0.002264 |
0.007417 |
1417 |
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS |
3 |
13 |
0.002264 |
0.007417 |
1418 |
REGULATION OF CELL FATE SPECIFICATION |
3 |
13 |
0.002264 |
0.007417 |
1419 |
NEGATIVE REGULATION OF GLUCONEOGENESIS |
3 |
13 |
0.002264 |
0.007417 |
1420 |
REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS |
3 |
13 |
0.002264 |
0.007417 |
1421 |
SKELETAL MUSCLE TISSUE REGENERATION |
4 |
27 |
0.002314 |
0.007536 |
1422 |
DEVELOPMENTAL INDUCTION |
4 |
27 |
0.002314 |
0.007536 |
1423 |
REGULATION OF ASTROCYTE DIFFERENTIATION |
4 |
27 |
0.002314 |
0.007536 |
1424 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
4 |
27 |
0.002314 |
0.007536 |
1425 |
DETECTION OF BIOTIC STIMULUS |
4 |
27 |
0.002314 |
0.007536 |
1426 |
LIPID STORAGE |
4 |
27 |
0.002314 |
0.007536 |
1427 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
4 |
27 |
0.002314 |
0.007536 |
1428 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS |
4 |
27 |
0.002314 |
0.007536 |
1429 |
FLUID TRANSPORT |
4 |
27 |
0.002314 |
0.007536 |
1430 |
INTRACELLULAR PROTEIN TRANSPORT |
29 |
781 |
0.00235 |
0.007647 |
1431 |
REGULATION OF NEUROTRANSMITTER LEVELS |
11 |
190 |
0.002378 |
0.007732 |
1432 |
NEGATIVE REGULATION OF DNA METABOLIC PROCESS |
8 |
111 |
0.002414 |
0.007843 |
1433 |
REGULATION OF RESPONSE TO OXIDATIVE STRESS |
6 |
65 |
0.002433 |
0.0079 |
1434 |
POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION |
5 |
45 |
0.002467 |
0.007977 |
1435 |
THYMOCYTE AGGREGATION |
5 |
45 |
0.002467 |
0.007977 |
1436 |
T CELL DIFFERENTIATION IN THYMUS |
5 |
45 |
0.002467 |
0.007977 |
1437 |
REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS |
5 |
45 |
0.002467 |
0.007977 |
1438 |
ENDOCHONDRAL BONE MORPHOGENESIS |
5 |
45 |
0.002467 |
0.007977 |
1439 |
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
5 |
45 |
0.002467 |
0.007977 |
1440 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
14 |
280 |
0.002573 |
0.008312 |
1441 |
PROTEIN AUTOPHOSPHORYLATION |
11 |
192 |
0.002579 |
0.008328 |
1442 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
6 |
66 |
0.00263 |
0.00848 |
1443 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
6 |
66 |
0.00263 |
0.00848 |
1444 |
REGULATION OF MEMBRANE POTENTIAL |
16 |
343 |
0.002644 |
0.008519 |
1445 |
VENTRICULAR SEPTUM MORPHOGENESIS |
4 |
28 |
0.002656 |
0.008522 |
1446 |
REGULATION OF FIBROBLAST MIGRATION |
4 |
28 |
0.002656 |
0.008522 |
1447 |
NEGATIVE REGULATION OF EXOCYTOSIS |
4 |
28 |
0.002656 |
0.008522 |
1448 |
NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY |
4 |
28 |
0.002656 |
0.008522 |
1449 |
RESPONSE TO GONADOTROPIN |
4 |
28 |
0.002656 |
0.008522 |
1450 |
MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
28 |
0.002656 |
0.008522 |
1451 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
11 |
193 |
0.002685 |
0.008609 |
1452 |
CEREBELLAR CORTEX DEVELOPMENT |
5 |
46 |
0.002721 |
0.008713 |
1453 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
5 |
46 |
0.002721 |
0.008713 |
1454 |
POSITIVE REGULATION OF CAMP METABOLIC PROCESS |
7 |
89 |
0.002728 |
0.008731 |
1455 |
AMINOGLYCAN METABOLIC PROCESS |
10 |
166 |
0.002777 |
0.008882 |
1456 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN |
3 |
14 |
0.002836 |
0.008972 |
1457 |
POSITIVE REGULATION OF NEURON DEATH |
6 |
67 |
0.002838 |
0.008972 |
1458 |
MACROMOLECULE DEACYLATION |
6 |
67 |
0.002838 |
0.008972 |
1459 |
POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS |
3 |
14 |
0.002836 |
0.008972 |
1460 |
POSITIVE REGULATION OF HISTONE DEACETYLATION |
3 |
14 |
0.002836 |
0.008972 |
1461 |
EPITHELIAL CELL CELL ADHESION |
3 |
14 |
0.002836 |
0.008972 |
1462 |
ETHANOL METABOLIC PROCESS |
3 |
14 |
0.002836 |
0.008972 |
1463 |
POSITIVE REGULATION OF P38MAPK CASCADE |
3 |
14 |
0.002836 |
0.008972 |
1464 |
RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE |
3 |
14 |
0.002836 |
0.008972 |
1465 |
POSITIVE REGULATION OF RENAL SODIUM EXCRETION |
3 |
14 |
0.002836 |
0.008972 |
1466 |
REGULATION OF MONOCYTE DIFFERENTIATION |
3 |
14 |
0.002836 |
0.008972 |
1467 |
CONVERGENT EXTENSION |
3 |
14 |
0.002836 |
0.008972 |
1468 |
NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
3 |
14 |
0.002836 |
0.008972 |
1469 |
CELLULAR RESPONSE TO VITAMIN D |
3 |
14 |
0.002836 |
0.008972 |
1470 |
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
3 |
14 |
0.002836 |
0.008972 |
1471 |
BONE MATURATION |
3 |
14 |
0.002836 |
0.008972 |
1472 |
REGULATION OF HISTONE H3 K9 ACETYLATION |
3 |
14 |
0.002836 |
0.008972 |
1473 |
POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
5 |
47 |
0.002993 |
0.009455 |
1474 |
REGULATION OF MEIOTIC NUCLEAR DIVISION |
4 |
29 |
0.00303 |
0.009533 |
1475 |
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
4 |
29 |
0.00303 |
0.009533 |
1476 |
STEM CELL DIVISION |
4 |
29 |
0.00303 |
0.009533 |
1477 |
REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS |
4 |
29 |
0.00303 |
0.009533 |
1478 |
REGULATION OF OLIGODENDROCYTE DIFFERENTIATION |
4 |
29 |
0.00303 |
0.009533 |
1479 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
10 |
168 |
0.003028 |
0.009533 |
1480 |
REGULATION OF PHAGOCYTOSIS |
6 |
68 |
0.003059 |
0.009617 |
1481 |
PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION |
8 |
116 |
0.003173 |
0.009969 |
1482 |
EPIDERMAL CELL DIFFERENTIATION |
9 |
142 |
0.003178 |
0.009979 |